UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Fiscal Year Ended March 31, 2017

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ______________

 

Commission File Number:  000-53489

 

Bravatek Solutions, Inc.

(Exact name of registrant as specified in its charter)

 

Colorado

 

32-0201472

(State or other jurisdiction of incorporation)

 

(IRS Employer Identification Number)

 

2028 E Ben White Blvd, #240-2835

Austin, TX 78741

(Address of principal executive offices)

 

866-204-6703

(Registrant's telephone number, including area code)

 

Securities registered under Section 12(b) of the Act:  None

 

Securities registered under Section 12(g) of the Act:  Common Stock, no par value

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ¨  Yes     x  No 

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ¨  Yes     x  No 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and smaller reporting company" in Rule 12b-2 of the Exchange Act. 

 

Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filer

¨

Smaller reporting company

x

(Do not check if a smaller reporting company)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ¨  Yes    x  No 

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of the last business day of the registrant's most recently completed second fiscal quarter; $23,500. Shares of the registrant’s common stock held by each executive officer and director and by each person who owned 10 percent or more of the registrant’s outstanding common stock were excluded in that such persons may be deemed to be “affiliates” of the Registrant for purposes of the above calculation. This determination of affiliate status is not a conclusive determination for other purposes.

 

As of September 27, 2017, the Company had 7,531,184,221 shares issued and outstanding.

 

 
 
 

PART I

 

ITEM 1. BUSINESS. 

 

Overview 

 

Bravatek Solutions, Inc., a Colorado corporation (the “Company"), was incorporated on April 19, 2007. Effective October 23, 2015, the Company changed its name to "Bravatek Solutions, Inc." in order to better reflect the Company's expanding operations and strategy. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, tools and systems, including telecom services. Solutions span a diverse variety of world-wide markets including, but not limited to, email security, user authentication, telecommunications and cyber breach protection.

 

Principal Products

 

Bravatek’s primary business focus centers on security, defense, and information security solutions that assist corporate entities, governments and individuals in protecting their organizations and/or critical infrastructure against both physical and cyber-attacks. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, tools and systems (including services). To date, the Company has earned limited revenue. The Company believes the majority of its revenues will be derived from sales of proprietary and allied products and services to large enterprises, government, and military customers within the United States (“U.S.”) and abroad.

 

Currently, the Company's primary business operations are focused on establishing a strategic leadership position in cybersecurity email solutions and telecom services within the U.S. and abroad. The Company also has a “Market Alliance Program” (“MAP”) that enables Bravatek to rapidly introduce additional allied software, tools and systems to the worldwide marketplace through “win-win” contracts offering Bravatek, in virtually all cases, exclusive distribution rights in specified markets.

 

Currently, the Company's primary proprietary product development efforts are focused on enhancing its sales-released enterprise-level information security software-appliance called  Ecrypt One . It was designed to protect email and attachments in transit and at rest. It incorporates and supports multiple security technologies and techniques, such as encryption, role based access controls, server rules that enforce security, and multi-factor authentication. It was designed, with our rigorous new product development process, to assist organizations and governments to meet and maintain compliance with information security regulations, such as the Health Insurance Portability and Accountability Care Act of 1996 (“HIPAA”). 

 

The Company has filed patent applications for multiple attributes and processes contained in  Ecrypt One .

 

On June 2, 2015, the Company completed an acquisition of some of the assets of Viking Telecom Services, LLC (“Viking Telecom”). The Company now provides telecom services under a new Viking Telecom brand. Services provided by Viking Telecom include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services. 

 

Research and Development 

 

Over the next twelve (12) months, Bravatek will continue developing new strategic alliances and strengthening existing strategic alliances. The Company also plans to continue developing enhancement upgrades to its proprietary cybersecurity product,  Ecrypt One.

 

Production

 

Ecrypt One  was developed using a proprietary, rigorous new product development process under the supervision of the Company’s CEO, Dr. Thomas A. Cellucci and Vice President of Product Development, Ian Treleaven. Solution testing and evaluation ("T&E") is routinely conducted by Ian Treleaven and the Company's development consultants using industry-standard tools and methods. The Company engages in technical meetings to address feedback from all T&E activities. 

 

 
2
 
 

 

Distribution

 

The Company distributes its solutions globally, in accordance with applicable import and export regulations, through a number of distribution channels. The primary method of distribution is through a dedicated in-house sales force. The Company is also pursuing strategic distribution alliances with data centers, service providers, carrier dealers, consultants, and complementary solution providers to distribute its product.

 

Additionally, the Company will list its solutions on the General Services Administration (“GSA”) Schedules or other government contract vehicles, for acquisition by authorized users. GSA is an independent agency of the United States government that, amongst other responsibilities, supplies products and communications for US government offices. The Company recently had its software related products and capabilities listed on the SEWP contract vehicle, administered by NASA, useable by many civilian and military agencies in the U.S.

 

Customers and Marketing 

 

Customers 

 

The Company offers products in multiple segments in government, business, and consumer markets. The majority of the allied products and services are targeted at government, military and business markets. 

 

The Company will primarily target Fortune 100 and 500 enterprises within the healthcare, financial/legal services, and telecommunications industries, as well as government, military and law enforcement agencies. These organizations have a critical reliance on security, defense, information security and data integrity products and services, and are subject to numerous stringent information security regulations.

 

The Company anticipates that a majority of its customers will be large sized businesses. The Company also anticipates sales of its products and services to U.S. government and military organizations, and allied foreign government and military organizations like NATO.

 

To date, the Company has received and fulfilled orders from corporate customers for Ecrypt One , Viking Telecom services, and partner solutions firms. 

 

Marketing 

 

Over the next twelve months, the Company will focus on orders and sales for its products and services. It will also continue to grow its strategic alliance network of allied products and service providers, who will also market Bravatek's products. 

 

The Company will focus its marketing efforts on customer acquisitions of  Ecrypt One  and Viking Telecom services, as well as allied products and services. The Company anticipates that it will continue to market its proprietary and allied products on the Internet, using the Company's websites (www.bravatek.com and www.vikingtelecomservices.com, not incorporated in this filing except as a reference), on social networking sites like Facebook and Twitter, and on industry websites, blogs and forums.

 

The Company also intends to expand its sales capabilities. 

 

Competition

 

Ecrypt One , the Company's enterprise-level information security server software package, is a very unique offering that faces indirect competition from companies such as: i) Symantec Corporation; ii) Voltage Security; iii) Proofpoint Inc.; iv) Axway Software; v) Watchguard; and, vi) Zix Corporation. 

 

All of the aforementioned companies develop and distribute email security servers. Although there is no assurance that we will be able to successfully compete with these organizations, our foremost advantage over these products is that  Ecrypt One unifies multiple technologies and benefits (including email, encryption, anti-virus, anti-malware, no spam and no phishing) into a single solution making its use and administration more effective and efficient. 

 

Allied products and services face competition from a variety of companies. 

 

Although there is no assurance that we will be able to successfully compete with these organizations, our foremost advantage over competition is our network of potential customers, our ability to access them, and the diversity of high-tech products and services that the Company offers. 

 

 
3
 
 

 

Intellectual Property and Agreements

 

Patents 

 

The Company has filed patent applications for multiple attributes and processes contained in  Ecrypt One .

 

Licenses 

 

The research, development and commercialization of cybersecurity software often involves alternative development and optimization routes, which are presented at various stages in the development process. The preferred routes cannot be predicted at the outset of a research and development program because they will depend upon subsequent discoveries and test results. There are numerous third-party patents in our field, and it is possible that to pursue the preferred development route of one or more of our products we will need to obtain a license to a patent, which would decrease the ultimate profitability of the applicable product. If we cannot negotiate a license, we might have to pursue a less desirable development route or terminate the program altogether.

 

Trade Secrets 

 

The Company also relies on trade secrets, proprietary know-how, and continuing technological innovation to develop and maintain a competitive position in our product areas. Bravatek employees, consultants and officers must sign a non-disclosure agreement before they are authorized to discuss particulars of the functionality of the Company's software products. All current employees, consultants and officers of the Company who are privy to confidential information have signed non-disclosure and non-competition agreements with the Company.

 

Environmental Issues 

 

Through the provision of Viking Telecom services, the Company currently assists private sector clients to safely maintain, upgrade and install telecommunication towers, assemblies, and parts to enhance communications and protect the environment. 

 

The Company's software products and their production or provision thereof, do not directly impact the environment. Notwithstanding the foregoing, the Company strives to be environmentally friendly in all aspects of its operations. 

 

Governmental Regulations 

 

Telecom services work performed under our Viking Telecom brand, is governed by the United States Occupational Safety and Health Administration (“OSHA”). OSHA is a federal organization (part of the United States Department of Labor) that ensures safe and healthy working conditions for Americans by enforcing standards and providing workplace safety training. 

 

Created in response to the Occupational Safety and Health Act of 1970, OSHA's main goal is to protect the rights and safety of workers by preventing workplace injuries and deaths and holding employers accountable for safe workplaces. OSHA provides workers and employers with information about hazardous working conditions and they offer free assessment for workplace dangers. 

 

There is a strict set of federal safety standards to which all businesses must adhere. These regulations cover things like disposal of hazardous materials, required personal safety equipment such as safety goggles, permitted noise levels and fall protection. OSHA inspects workplaces to ensure they're following all regulations to reduce chances of accident or injury. 

 

Cybersecurity Software is classified as a "dual-use good," meaning that it can be used by both the general public and the military. Export of such goods is regulated by the Wassenaar Arrangement on Export Controls for Conventional Arms and Dual-Use Goods and Technologies (the "Wassenaar Arrangement"). 

 

The Wassenaar Arrangement was established in order to contribute to regional and international security and stability by promoting transparency and greater responsibility in transfers of conventional arms and dual-use goods and technologies, thus preventing destabilizing accumulations. Participating States seek, through their national policies, to ensure that transfers of these items do not contribute to the development or enhancement of military capabilities, which undermine these goals, and are not diverted to support such capabilities. 

 

 
4
 
 

 

The Participating States of the Wassenaar Arrangement include: Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Luxembourg, Malta, Netherlands, New Zealand, Norway, Poland, Portugal, Republic of Korea, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom and United States.

 

In the United States, the Bureau of Industry and Security ("BIS") is responsible for implementing and enforcing the Export Administration Regulations ("EAR"), which regulate the export and re-export of most commercial items. Encryption software is subject to the EAR and other U.S. law, and may not be exported or re-exported to certain countries (currently Cuba, Iran, North Korea, Sudan and Syria) or to persons or entities prohibited from receiving US exports. Because of this, the Company has applied and has received approval for Mass Market Status Export Authorization from the BIS. Mass Market Status is given to encryption products, which have been reviewed and classified by the BIS as exportable under certain rules and regulations, including the mass-market encryption rules of the EAR.

 

The procurement and use of commercially available security solutions by government, and military agencies is controlled through various regulations. In order to provide or sell a service or product to a government or military agency, a vendor or provider can be approved by and listed with the United States General Services Administration (“GSA”) or other US government contract vehicles. Additionally, military applications also require that products be certified by the National Security Agency. The Company is pursuing such certifications and accreditations. The Company is also working with Steptoe & Johnson to determine other regulatory requirements for  Ecrypt One enterprise-level information security soft-appliance. 

 

Employees

 

The Company currently has one full-time employee, its Chief Executive Officer, Dr. Thomas A. Cellucci. Deborah King is contracted to act as Interim Chief Financial Officer. Ian Treleaven is contracted to act as Vice President of Product Development of the Company. Various consultants have been contracted to fulfill sales, software development and web programming duties.

 

Reports to Security Holders

 

Once filed with the SEC, the Company provides its annual report that includes its audited financial information to its shareholders upon written request. The Company also makes its financial information equally available to any interested parties or investors through compliance with the disclosure rules of the Exchange Act. The Company is subject to disclosure filing requirements including filing Form 10-K's annually and Form 10-Q's quarterly. In addition, the Company files current reports on Form 8-K and other proxy and information statements from time to time as required.

 

The public may read and copy any materials that the Company files with the SEC at the SEC's Public Reference Room at 100 F Street NE, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website (http://www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

 

ITEM 1A. RISK FACTORS. 

 

Not required for Smaller Reporting Companies.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS. 

 

Not Applicable. 

 

 
5
 
 

 

ITEM 2. PROPERTIES.

 

The Company does not currently own any real property. Currently, the Company's principal business address is 2028 E. Ben White Blvd., #240-2835, Austin, TX 78741. The costs associated are immaterial to the financial statements and, accordingly have not been reflected therein. The Company anticipates that it will explore leasing opportunities for office space during the next twelve months. 

 

The Company uses a combination of U.S.-based cloud services and a Canadian co-location facility to host its email and development servers. 

 

Bravatek owns the following internet domain names:

 

6REPLY.COM, 6REPLY.INFO, 6SEND.COM, 6SEND.INFO, BRAVATEK.COM, ECRYPTINC.CA, ECRYPTMAIL.INFO, SECUREINFORMATIONXCHANGE.COM, SECUREINFORMATIONXCHANGE.INFO, SIXREPLY.INFO, SIXSEND.INFO, SIXSMB.COM, SIXSMB.INFO, VIKINGTELECOMSERVICES.COM. The contents of these domains are not incorporated in this document. 

 

ITEM 3. LEGAL PROCEEDINGS.

 

The Company is not a party to any significant pending legal proceedings other than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.

 

On or about April 13, 2015, the Company was served with a lawsuit filed by George Sharp against the Company and numerous other defendants in the Superior Court of the State of California, with a cause of action against the Company for its alleged participation in sending "spam" emails to Mr. Sharp. The Company did not participate in sending any emails to Mr. Sharp, retained California litigation counsel, and filed a demurrer in California. On, or about, June 3, 2015, the Company entered into a settlement agreement, and the case against the Company was subsequently dismissed with prejudice.

 

On July 16, 2015, the Company's then independent certifying accounting firm, Sadler Gibb & Associates, LLC, notified the Company during a phone call that a consultant, Jay Lake, to the Company's outside accountant, One Blue Mountain, was subject to a PCAOB order barring Mr. Lake from being an associated person of a registered public accounting firm. Pursuant to Section 105(c)(7) of the Sarbanes-Oxley Act of 2002, it is unlawful for a person subject to such an association bar to willfully associate with an issuer in an accountancy or a financial management capacity without the consent of the PCAOB or the Securities and Exchange Commission, and for an issuer to permit such person to associate with the issuer if the issuer knew or should have known in the exercise of reasonable care of the association bar. On July 17, 2015, the Company transitioned to using another outside accountant in lieu of One Blue Mountain, and on July 22, 2015, formally terminated One Blue Mountain. On July 21, 2015, the Company reported the matter to the Securities and Exchange Commission.

 

On January 27, 2016, one of the Company’s creditors, JSJ Investments, Inc. (“JSJ”), sent a demand for payment of amounts allegedly owed by the Company to JSJ pursuant to a convertible note dated January 19, 2015, in the original principal amount of $100,000, and threatening potential legal action against the Company. On or about September 5, 2017, JSJ assigned its interest in the note to Carebourn Partners, LLC, and the Company and JSJ mutually released each other from all claims.

 

On April 21, 2017, the Company, Dr. Cellucci and TCA Global Credit Master Fund, LP (“TCA”) executed a settlement agreement (the “Settlement Agreement”). Pursuant to the Settlement Agreement, the Company agreed to pay $2,500 by April 30, 2017, $2,500 by May 31, 2017 and $405,357 on or before June 16, 2017. The Company has fully complied with its obligations under the settlement agreement, paying TCA all amounts owed thereunder within the times required, and the case has now been dismissed.

 

On or about December 7, 2016, Bears Global Construction Holdings, LLC (“Bears”) commenced an action against the Company in the County Court at Law No. 1 for Travis County, Texas, the Company denied liability and filed a counterclaim and motion to dismiss, and the parties entered into a settlement agreement on or about February 23, 2017, whereby they each released the other party from all claims. The case was subsequently dismissed.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not Applicable. 

 

 
6
 
 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

Market Information

 

The Company's shares are approved for trading on the OTCBB under the symbol "BVTK." The following table sets forth the high and low bid prices of our common stock (USD) for the last two fiscal years as reported by the National Quotation Bureau and represents inter dealer quotations, without retail mark-up, mark-down or commission and may not be reflective of actual transactions: 

 

 

 

(U.S. $)

 

Fiscal year ended March 31, 2017

 

HIGH 

 

 

LOW 

 

Quarter ended June 30, 2016 

 

$ 0.50

 

 

$ 0.03

 

Quarter ended September 30, 2016 

 

$ 0.06

 

 

$ 0.0003

 

Quarter ended December 31, 2016

 

$ 0.0004

 

 

$ 0.0001

 

Quarter ended March 31, 2017

 

$ 0.0001

 

 

$ 0.0001

 

 

 

 

 

 

 

 

 

 

Fiscal year ended March 31, 2016 

 

HIGH 

 

 

LOW 

 

Quarter ended June 30, 2015 

 

$ 1,032.50

 

 

$ 400.00

 

Quarter ended September 30, 2015 

 

$ 412.50

 

 

$ 20.00

 

Quarter ended December 31, 2015 

 

$ 30.00

 

 

$ 1.00

 

Quarter ended March 31, 2016 

 

$ 1.75

 

 

$ 0.245

 

 

Holders

 

As of September 27, 2017, there were 7,504,753,161 shares of common stock issued and outstanding and approximately 140 shareholders of record.

 

Dividends

 

The Company has not declared or paid any cash dividends on its common stock during the fiscal years ended March 31, 2017, or 2016. There are no restrictions on the common stock that limit our ability to pay dividends if declared by the Board of Directors and the loan agreements and general security agreements covering the Company's assets do not limit its ability to pay dividends. The holders of common stock are entitled to receive dividends when and if declared by the Board of Directors, out of funds legally available therefore and to share pro-rata in any distribution to the stockholders. Generally, the Company is not able to pay dividends if after payment of the dividends, it would be unable to pay its liabilities as they become due or if the value of the Company's assets, after payment of the liabilities, is less than the aggregate of the Company's liabilities and stated capital of all classes. 

 

ITEM 6. SELECTED FINANCIAL DATA. 

 

Not Applicable.

 

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

SPECIAL NOTE OF CAUTION REGARDING FORWARD-LOOKING STATEMENTS 

 

Certain statements in this report, including statements in the following discussion, are what are known as "forward looking statements," which are basically statements about the future. For that reason, these statements involve risk and uncertainty since no one can accurately predict the future. Words such as "plans," "intends," "will," "hopes," "seeks," "anticipates," "expects" and the like often identify such forward looking statements, but are not the only indication that a statement is a forward-looking statement. Such forward looking statements include statements concerning our plans and objectives with respect to the present and future operations of the Company, and statements which express or imply that such present and future operations will or may produce revenues, income or profits. Numerous factors and future events could cause the Company to change such plans and objectives or fail to successfully implement such plans or achieve such objectives, or cause such present and future operations to fail to produce revenues, income or profits. Therefore, the reader is advised that the following discussion should be considered in light of the discussion of risks and other factors contained in this report on Form 10-K and in the Company's other filings with the Securities and Exchange Commission. No statements contained in the following discussion should be construed as a guarantee or assurance of future performance or future results. 

 

 
7
 
 

 

Overview and Plan of Operation 

 

Bravatek Solutions, Inc., a Colorado corporation, was incorporated in the State of Colorado, on April 19, 2007. The Company provides security, defense, and information security solutions, which assist corporate entities, governments and individuals in protecting their organizations and/or critical infrastructures against error, and physical and cyber-attack. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, tools and systems, including telecom services. Solutions span a diverse variety of world-wide markets including, but not limited to, email security, user authentication, telecommunications and cyber breach protection.

 

Currently, the Company's primary business operations are focused on establishing a strategic leadership position in cybersecurity email solutions and telecom services within the U.S. and abroad. The Company also has a “Market Alliance Program” (“MAP”) that enables Bravatek to rapidly introduce additional allied software, tools and systems to the worldwide marketplace through “win-win” contracts offering Bravatek, in virtually all cases, exclusive distribution rights in specified markets.

 

Additionally, the Company has developed and plans to continue selling an enterprise-level secure email software appliance named  Ecrypt One. Ecrypt One  is an email server with integrated security technology. It was designed to protect email and attachments in transit and at rest. It incorporates multiple security technologies and techniques, such as encryption, role based access controls, server rules that enforce security, and multi-factor authentication. It was designed to assist organizations and governments to meet and maintain compliance with information security regulations such as HIPAA.

 

The Company has filed patent applications for multiple attributes and processes contained in  Ecrypt One .

 

On June 2, 2015, the Company strategically acquired some of the assets of Viking Telecom Services, LLC, a Minnesota limited liability company ("Viking”) from Dependable Critical Infrastructure, Inc. f/k/a DTREDS Consolidated Inc., a Delaware corporation ("DCI"). The Company continues to provide telecommunication services under the "Viking," "Viking Telecom," and "Viking Tower" brands. Services provided include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services.

 

On June 6, 2017, the Company entered into a Strategic Alliance Agreement with HelpComm, Inc. (“HelpComm”), a telecom construction services corporation located in Manassas, Virginia, pursuant to which the Company would provide at least $200,000 in business expansion funding to HelpComm within ten (10) business days of execution of the agreement, and 40% of profits from services performed by HelpComm pursuant to receipt of the expansion funding from the Company would be allotted to the Company. The Company remitted the $200,000 to HelpComm on June 26, 2017, and expects revenue from Helpcomm from orders already received by HelpComm. On September 20, 2017, the Company entered into a Letter of Intent to potentially acquire Helpcomm.

 

In addition to the foregoing, in an effort to advance the business operations of the Company, over the next twelve (12) months the Company plans to undertake the following actions in the order in which they are listed:

 

1.

Continue distribution on Ecrypt One Software packages;

2.

Continue providing telecom services;

3.

Continue distribution of allied products and services;

4.

Continue developing strategic marketing alliance program; and

5.

Continue development and testing of additional Ecrypt One features and capabilities.

 

The foregoing business actions are goals of the Company. There is no assurance that the Company will be able to complete any, or all, of the foregoing actions.

 

On May 31, 2016, the registrant filed Articles of Amendment to increase the number of shares of common stock the corporation is authorized to issue to 10,000,000,000. 

 

On June 17, 2016, the Financial Industry Regulatory Authority ("FINRA") announced the registrant's 1:2,500 reverse stock split of the registrant's common stock. The reverse stock split took effect on June 20, 2016. Unless otherwise noted, impacted amounts and share information included in the financial statements and notes thereto have been retroactively adjusted for the stock split as if such stock split occurred on the first day of the first period presented. Certain amounts in the notes to the financial statements may be slightly different than previously reported due to rounding of fractional shares as a result of the reverse stock split.

 

 
8
 
 

 

Results of Operations 

 

The following discussion and analysis provides information that we believe is relevant to an assessment and understanding of our results of operation and financial condition for the fiscal year ended March 31, 2017, as compared to the fiscal year ended March 31, 2016. The following discussion should be read in conjunction with the Financial Statements and related Notes appearing elsewhere in this Form 10-K. 

 

Our financial statements are stated in U.S. Dollars and are prepared in accordance with generally accepted accounting principles of the United States ("GAAP"). 

 

Results of Operation for Bravatek Solutions, Inc. for the Fiscal Year Ended March 31, 2017, Compared to the Fiscal Year Ended March 31, 2016. 

 

Revenue

 

For the fiscal year ended March 31, 2017, the Company had revenues of $203,054 as compared to revenues of $391,872 for the fiscal year ended March 31, 2016. For the year ended March 31, 2017, revenues of $23,625 were recorded in barter transactions in exchange for advertising and promotional expenses. Related party and other revenue for the years ended March 31, 2017, and 2016, were as follows:

 

 

 

Sales Year Ended March 31,

2017

 

 

Sales Year Ended March 31,

2016

 

Revenue, related party

 

$ 145,362

 

 

$ 186,837

 

Revenue, other

 

 

57,692

 

 

 

205,035

 

Total revenue

 

$ 203,054

 

 

$ 391,872

 

 

The related party for the year ended March 31, 2017, was temporarily a related party based on the percentage of shares owned by management of the related party, of the issued and outstanding common stock of the Company at the time of the sales. The party is no longer a related party. For the year ended March 31, 2016, the Company recorded sales to three related party companies in the amounts of $126,148, $59,404 and $1,750, respectively. The sales of $1,750 were to a limited liability company controlled by our chief executive officer (“CEO”).

 

Operating Expenses 

 

For the year ended March 31, 2017, the Company had operating expenses of $544,586 compared to $1,808,992 for the year ended March 31, 2016. The decrease in operating expenses experienced by the Company was primarily attributable to significant decreases in research and development, professional fees, general and administrative costs and advertising and promotional costs.

 

Other Income (Expenses)

 

Other expenses for the year ended March 31, 2017, decreased to $837,433 from $3,734,871 for the year ended March 31, 2016. The decrease was primarily due to a decrease in the fair value of derivatives of $67,603 for the year ended March 31, 2017, compared to an increase in the fair value of derivatives of $942,280 for the year ended March 31, 2016. Amortization of debt discount decreased by $552,922 as several notes reached their maturity during the year ended March 31, 2016, and were fully amortized that year. Other expenses in the year ended March 31, 2016, included the loss on acquisition of assets from a related party and loss on investment in unconsolidated investee.

 

Net Loss

 

The Company had a net loss of $1,334,396 for the year ended March 31, 2017, compared to $5,351,059 for the year ended March 31, 2016. The change in net loss was primarily attributable to the decreases in operating expenses and other expenses as described above.

 

 
9
 
 

 

Liquidity and Capital Resources 

 

Currently, we have limited operating capital. The Company anticipates that it will require approximately $4,000,000 of working capital to complete all of its desired business activity during the next twelve months. The Company has earned limited revenue from its business operations. Our current capital and our other existing resources will be sufficient only to provide a limited amount of working capital, and, to date, the revenues generated from our business operations have not been sufficient to fund our operations or planned growth. As noted above, we will likely require additional capital to continue to operate our business, and to further expand our business. We may be unable to obtain the additional capital required. Our inability to generate capital or raise additional funds when required will have a negative impact on our operations, business development and financial results.

 

For the fiscal year ended March 31, 2017, we primarily funded our business operations with the proceeds from convertible note financing. Since April 1, 2017, through September 20, 2017, we received proceeds of $1,467,030 from the issuance of $1,664,947 of convertible promissory notes. These activities funded our business operations from March 31, 2017, and were also used to pay off existing debt of approximately $754,000, and to fund $200,000 for our Strategic Alliance Agreement with Helpcomm. We may conduct a private placement offering to seek to raise the necessary working capital to continue to fund our business operations, or continue to rely on the issuance of convertible promissory notes to fund our business operations.

 

As of March 31, 2017, we had cash of $125, as compared to $15,244 at March 31, 2016. As of March 31, 2017, we had current liabilities of $5,174,058 (including $1,654,015 of non-cash derivative liabilities) which resulted in working capital deficit of $5,173,933. The current liabilities are comprised of accounts payable, accrued expenses, convertible debt, note payable-related party, notes payable, accounts payable and accrued expenses and derivative liabilities.

 

Operating Activities  

 

For the year ended March 31, 2017, net cash used in operating activities was $80,065 compared to $1,469,120 for the year ended March 31, 2016. For the year ended March 31, 2017, adjustments to the net loss included $633,732 for the amortization of debt discount, $76,380 of common stock and options expensed for services, and net changes of $520,157 in operating assets and liabilities positively impacted the cash used in operating activities. For the year ended March 31, 2016, our net cash used in operating activities was primarily attributable to the net loss adjusted by amortization of debt discounts, derivative liability expenses, loss on assets acquired from related party, non-cash interest and fees related to convertible promissory notes and depreciation. Net increases of $259,173 in operating assets and liabilities also reduced the cash used in operating activities.

 

Investing Activities  

 

During the fiscal year ended March 31, 2017, there was no investing activity, compared to net cash used in investing activities of $200,280 for the year ended March 31, 2016. The 2016 net cash used by investing activities was primarily attributable to the fact that the Company purchased assets per the Asset Purchase Agreement with DCI dated June 2, 2015.

 

Financing Activities  

 

During the year ended March 31, 2017, the net cash provided by financing activities was $64,946 compared to $1,481,573 for the year ended March 31, 2016. The results for the year ended March 31, 2017, was the result of proceeds received of $48,000 from the issuance of $61,239 of convertible promissory notes, receipt of $31,850 of proceeds from a related party loan and the repayments of $12,224 against convertible promissory notes and $3,500 of repayments of note payable. The activity for the year ended March 31, 2016, was the result of proceeds from notes payable of $310,600, convertible promissory notes of $1,161,424, and proceeds received from a related party of $156,512 and repayments of $51,512 related party loan obligations and $95,451 note repayments.

 

Off Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition or results of operations.

 

Significant Accounting Policies

 

Basis of Presentation 

 

The financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America ("U.S. GAAP").

 

 
10
 
 

 

Use of Estimates 

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. 

 

Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities. 

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, actual results could differ significantly from estimates. 

 

Cash and Cash Equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less. The Company had no cash equivalents.

 

Accounts Receivable/Allowance for Doubtful Accounts

 

The Company records its client receivables and unbilled services at their face amounts less allowances. On a periodic basis, the Company evaluates its receivables and unbilled services and establishes allowances based on historical experience and other currently available information. As of March 31, 2017, and 2016, management determined there was no need to establish an allowance for doubtful accounts because there had been little history of nonpayment or indicators of credit risk, such as bankruptcy.

 

Property and Equipment

 

Property and equipment is stated at cost, less accumulated depreciation and is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5-7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. 

 

Software Development Costs

 

Costs for software developed for internal use are accounted for through the capitalization of those costs incurred in connection with developing or obtaining internal-use software. Capitalized costs for internal-use software are included in intangible assets in the consolidated balance sheet. Capitalized software development costs are amortized over three years.

 

Costs incurred during the preliminary project along with post-implementation stages of internal use computer software development and costs incurred to maintain existing product offerings are expensed as incurred. The capitalization and ongoing assessment of recoverability of development costs require considerable judgment by management with respect to certain external factors, including, but not limited to, technological and economic feasibility and estimated economic life. Capitalized software is amortized over the software's estimated economic life of 3 years. For the years ended March 31, 2017, and 2016, amortization expense for capitalized software development was $20,121 and $20,176, respectively.

 

Long-Lived Assets 

 

The Company reviews long-lived assets and certain identifiable intangibles held and used for possible impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In evaluating the fair value and future benefits of its intangible assets, management performs an analysis of the anticipated undiscounted future net cash flow of the individual assets over the remaining amortization period. The Company recognizes an impairment loss if the carrying value of the asset exceeds the expected future cash flows.

 

 
11
 
 

 

Research and Development

 

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with GAAP. All research and development costs have been expensed as incurred, totaling $29,998 and $492,986 for the years ended March 31, 2017, and 2016, respectively. The company had no development costs required to be capitalized under ASC 985-20,  Costs of Software to be Sold, Leased or Marketed,  and under ASC 350-40,  Internal-Use Software,  in the years ended March 31, 2017 and 2016.

 

Advertising and Promotions  

 

The Company expenses advertising costs as incurred. Advertising expenses for the year ended March 31, 2017, and 2016, were $26,074 and $105,778, respectively.

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. 

 

The following are the hierarchical levels of inputs to measure fair value: 

 

 

·

Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

 

·

Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

·

Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments. 

 

The following table represents the Company’s financial instruments that are measured at fair value on a recurring basis as of March 31, 2017 and 2016, for each fair value hierarchy level:

 

March 31, 2017

 

Derivative

Liability

 

 

Total

 

Level I

 

$ -

 

 

$ -

 

Level II

 

$ -

 

 

$ -

 

Level III

 

$ 1,654,015

 

 

$ 1,654,015

 

March 31, 2016

 

 

 

 

 

 

 

 

Level I

 

$ -

 

 

$ -

 

Level II

 

$ -

 

 

$ -

 

Level III

 

$ 1,955,721

 

 

$ 1,955,721

 

 

Embedded Conversion Features

 

The Company evaluates embedded conversion features within convertible debt under ASC 815 "Derivatives and Hedging" to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 "Debt with Conversion and Other Options" for consideration of any beneficial conversion feature. 

 

Derivative Financial Instruments

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. 

 

For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. 

 

 
12
 
 

 

Debt Discount

 

The Company determined that the conversion feature of issued convertible notes represent an embedded derivative since the notes are convertible into a variable number of shares upon conversion. Accordingly, the notes were not considered to be conventional debt under EITF 00-19 and the embedded conversion feature was bifurcated from the debt host and accounted for as a derivative liability. The fair value of these derivative instruments are recorded as a liability on the consolidated balance sheet with the corresponding amount recorded as a discount to each Note. Such discount is being amortized from the date of issuance to the maturity dates of the Notes. 

 

Revenue Recognition

 

Product revenue and miscellaneous income are recognized as earned.

 

The Company recognizes revenue and gains when earned and related costs of sales and expenses when incurred. The Company recognizes revenue in accordance with Accounting Standards Codification Section 605-10-S99, Revenue Recognition, Overall, SEC Materials ("Section 605-10-S99"). Section 605-10-S99 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. The Company recognizes revenue from services at the time the services are completed. The Company’s sale of licensed software has significant standalone functionality with a perpetual right to use the Company’s intellectual property. Accordingly, the Company recognizes licensed software revenue at the time the software is delivered or available to the customer, at which time the company had no further obligations related to the sale of the software. Cost of products sold consists of the cost of the purchased goods and labor related to the corresponding sales transaction.

 

Stock-Based Compensation – Employees

 

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.

 

The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model.

 

Generally, all forms of share-based payments, including stock option grants, warrants and restricted stock grants and stock appreciation rights are measured at their fair value on the awards' grant date, based on estimated number of awards that are ultimately expected to vest. 

 

Related Parties

 

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. 

 

Pursuant to Section 850-10-20 the related parties include a) affiliates of the Company; b) Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. 

 

 
13
 
 

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. 

 

On June 2, 2015, the Company completed an acquisition of some of the assets and assumed certain liabilities of Viking Telecom Services, LLC (“Viking Telecom”) from Dependable Critical Infrastructure, Inc. (“DCI,” f/k/a DTREDS Consolidated, Inc.). To acquire the assets, the Company issued 2,265 shares of common stock, 224 shares of common stock to be issued (valued in the aggregate at $740,000), paid $200,000 cash and forgave $59,204 of a note receivable from DCI. The Company now provides telecom services under a new Viking Telecom brand. Services provided by Viking Telecom include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services. At the time of the acquisition, our CEO owned approximately 30% of DCI. The Company recorded a loss on the acquisition of $1,044,817 for the year ended March 31, 2016.

 

Net Earnings (Loss) per Share 

 

Basic and diluted net loss per share information is presented under the requirements of ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, less shares subject to repurchase. Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, warrants and convertible notes in the weighted-average number of common shares outstanding for a period, if dilutive. As of March 31, 2017, there were warrants and options to purchase 3,365 shares of common stock and the Company’s outstanding convertible debt is convertible into approximately 22,762,118,935 shares of common stock. These amounts are not included in the computation of dilutive loss per share because their impact is antidilutive.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. 

 

Not Applicable. 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA. 

 

The financial statements of the Company required by Article 8 of Regulation S-X are attached to this report. 

 

 
14
 
 

 

BRAVATEK SOLUTIONS, INC.

AUDITED FINANCIAL STATEMENTS

FOR THE FISCAL YEARS ENDED MARCH 31, 2017 AND 2016

 

 

 

Page  

 

Report of Independent Registered Public Accounting Firm 

 

F-1

 

Balance Sheets 

 

F-2

 

Statements of Operations 

 

F-3

 

Statement of Stockholders' Deficit 

 

F-4

 

Statements of Cash Flows 

 

F-5

 

Notes to Financial Statements 

 

F-6

 

   

 
15
 
Table of Contents

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of Bravatek Solutions, Inc.

 

We have audited the accompanying balance sheets of Bravatek Solutions, Inc. as of March 31, 2017 and 2016, and the related statements of operations, stockholders’ deficit, and cash flows for each of the years then ended. Bravatek Solutions, Inc.’s management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Bravatek Solutions, Inc. as of March 31, 2017 and 2016, and the results of its operations and its cash flows for each of the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, under Uncertainty as a Going Concern , the Company has suffered recurring losses from operations since inception. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plan regarding these matters is also described in Note 2 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

 

D. Brooks and Associates CPA’s, P.A.

West Palm Beach, Florida

September 25, 2017

 

 
F-1
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

BALANCE SHEETS

 

 

 

 

March 31,

 

 

March 31,

 

 

 

2017

 

 

2016

 

ASSETS

 

CURRENT ASSETS

 

 

 

 

 

 

Cash

 

$ 125

 

 

$ 15,244

 

Accounts receivable

 

 

-

 

 

 

46,898

 

Prepaid expenses

 

 

-

 

 

 

1,150

 

Other assets

 

 

-

 

 

 

9,952

 

TOTAL CURRENT ASSETS

 

 

125

 

 

 

73,244

 

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

 

28,661

 

 

 

37,631

 

Intangible assets, net

 

 

16,813

 

 

 

36,934

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$ 45,599

 

 

$ 147,809

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Convertible notes payable, net of discounts

 

$ 1,271,727

 

 

$ 854,396

 

Notes payable, net of discounts

 

 

1,170,450

 

 

 

1,093,598

 

Notes payable, related party 

 

 

136,850

 

 

 

105,000

 

Bank overdraft

 

 

820

 

 

 

-

 

Accounts payable and accrued liabilities 

 

 

205,312

 

 

 

136,831

 

Accounts payable - related party 

 

 

286,442

 

 

 

106,500

 

Accrued interest 

 

 

425,290

 

 

 

246,745

 

Accrued interest related party 

 

 

23,153

 

 

 

11,550

 

Derivative liabilities 

 

 

1,654,015

 

 

 

1,955,721

 

TOTAL CURRENT LIABILITIES

 

 

5,174,058

 

 

 

4,510,341

 

 

 

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENT LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

Series A convertible preferred stock (5,000,000 shares authorized; par

 

 

value $0.0001, -0- shares issued and outstanding at

 

 

 

 

 

 

 

 

March 31, 2017, and 2016)

 

 

-

 

 

 

-

 

Series B preferred stock (350,000 shares authorized; par

 

 

 

 

 

 

 

 

value $0.0001, 264,503 shares issued and outstanding at

 

 

 

 

 

 

 

 

March 31, 2017, and 2016)

 

 

26

 

 

 

26

 

Series C preferred stock (1,000,000 shares authorized; par

 

 

 

 

 

 

 

 

value $0.0001, 319,768 shares issued and outstanding at

 

 

 

 

 

 

 

 

March 31, 2017 and 2016)

 

 

32

 

 

 

32

 

Common stock (10,000,000,000 shares authorized; no par value; 

 

 

 

 

 

 

 

 

2,053,703,772 and 998,236 shares issued and outstanding at

 

 

 

 

 

 

 

 

March 31, 2017, and 2016, respectively)

 

 

3,734,786

 

 

 

3,461,300

 

Common stock to be issued (1,221 shares issuable

 

 

 

 

 

 

 

 

at March 31, 2017, and 2016)

 

 

66,917

 

 

 

66,917

 

Deferred stock compensation

 

 

-

 

 

 

(5,380 )

Additional paid in capital

 

 

10,170,515

 

 

 

9,880,912

 

Accumulated deficit 

 

 

(19,100,734 )

 

 

(17,766,338 )

TOTAL STOCKHOLDERS' DEFICIT

 

 

(5,128,459 )

 

 

(4,362,532 )

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

 

$ 45,599

 

 

$ 147,809

 

 

The accompanying notes are an integral part of these financial statements.

  

 
F-2
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

STATEMENTS OF OPERATIONS

 

 

 

 

 

 

 

 

 

For the Year Ended

March 31,

 

 

 

2017

 

 

2016

 

REVENUES

 

 

 

 

 

 

Sales, related parties

 

$ 145,362

 

 

$ 186,837

 

Sales, other

 

 

57,692

 

 

 

205,035

 

Total revenue

 

 

203,054

 

 

 

391,872

 

Cost of services

 

 

155,431

 

 

 

199,068

 

GROSS PROFIT

 

 

47,623

 

 

 

192,804

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

Management fees and expenses, related parties

 

 

212,000

 

 

 

118,678

 

Advertisement and promotion 

 

 

26,074

 

 

 

105,778

 

General and administrative 

 

 

46,351

 

 

 

519,524

 

Research and development

 

 

29,998

 

 

 

492,986

 

Professional fees 

 

 

201,073

 

 

 

539,861

 

Amortization and depreciation 

 

 

29,090

 

 

 

32,165

 

TOTAL OPERATING EXPENSES 

 

 

544,586

 

 

 

1,808,992

 

 

 

 

 

 

 

 

 

 

OPERATING LOSS 

 

 

(496,963 )

 

 

(1,616,188 )

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSES) 

 

 

 

 

 

 

 

 

Interest expense 

 

 

(274,101 )

 

 

(403,666 )

Interest expense related party 

 

 

(11,603 )

 

 

(11,550 )

Loss on acquisition of assets from related party

 

 

-

 

 

 

(1,044,817 )

Loss on investment in unconsolidated investee

 

 

-

 

 

 

(150,000 )

Other income

 

 

14,400

 

 

 

-

 

Gain (loss) on fair value of derivatives

 

 

67,603

 

 

 

(942,280 )

Gain on extinguishment of debt 

 

 

-

 

 

 

4,096

 

Amortization of debt discounts

 

 

(633,732 )

 

 

(1,186,654 )

TOTAL OTHER EXPENSES, NET

 

 

(837,433 )

 

 

(3,734,871 )

 

 

 

 

 

 

 

 

 

NET LOSS

 

$ (1,334,396 )

 

$ (5,351,059 )

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE SHARES OUTSTANDING 

 

 

 

 

 

 

 

 

Basic and diluted 

 

 

162,920,226

 

 

 

158,967

 

 

 

 

 

 

 

 

 

 

LOSS PER SHARE

 

 

 

 

 

 

 

 

Basic and diluted 

 

$ (0.01 )

 

$ (33.66 )

 

The accompanying notes are an integral part of these financial statements.

   

 
F-3
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

STATEMENTS OF STOCKHOLDERS' DEFICIT

FOR THE YEARS ENDED MARCH 31, 2017 and 2016

   

 

Preferred Stock

 

 

 

 

 

Common Stock to

 

Additional

 

Deferred

 

 

 

Total

 

Series A

 

Series B

 

Series C

 

Common Stock

 

be issued

 

Paid in

 

Stock

 

Retainted

 

Stockholders'

 

 

Shares

 

Amount

 

Shares

 

Amount

 

Shares

 

Amount

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Compenstion

 

Deficit

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance April 1, 2015

 

5,000,000

$

500

 

-

$

-

 

-

$

-

 

6,429

$

2,072,814

 

59

$

55,480

$

8,150,332

$

-

$

(12,415,279)

$

(2,136,153)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock for shares to be issued

 

-

 

-

 

-

 

-

 

-

 

-

 

59

 

55,480

 

(59)

 

(55,480)

 

-

 

-

 

-

 

-

Rounding up for reverse split

 

-

 

-

 

-

 

-

 

-

 

-

 

347

 

-

 

-

 

-

 

-

 

-

 

-

 

-

Issuances of Series B preferred stock, common stock issued and common stock to be issued for assets acquired from related party

 

-

 

-

 

264,503

 

26

 

-

 

-

 

1,208

 

673,319

 

224

 

66,655

 

-

 

-

 

-

 

740,000

Common stock issued for conversion of convertible debt and accrued interest

 

-

 

-

 

-

 

-

 

-

 

-

 

989,190

 

575,719

 

-

 

-

 

-

 

-

 

-

 

575,719

Common stock issued for interest pursuant to Credit Agreement

 

-

 

-

 

-

 

-

 

-

 

-

 

1,412

 

75,000

 

-

 

-

 

-

 

-

 

-

 

75,000

Cancellation of common stock for Series C preferred stock from related party

 

-

 

-

 

-

 

-

 

319,768

 

32

 

(1,279)

 

(32)

 

-

 

-

 

208,951

 

-

 

-

 

208,951

Agreement for cancellation of Series A preferred stock and common stock to be issued

 

(2,622,500)

 

(262)

 

-

 

-

 

-

 

-

 

-

 

-

 

997

 

262

 

-

 

-

 

-

 

-

Cancellation of Series A preferred stock and issuance of common stock

 

(2,377,500)

 

(238)

 

-

 

-

 

-

 

-

 

856

 

-

 

-

 

-

 

238

 

 

 

-

 

-

Debt forgiveness from stockholder

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

 

 

 

 

 

 

426,460

 

 

 

 

 

426,460

Common stock issued for legal services 

 

-

 

-

 

-

 

-

 

-

 

-

 

14

 

9,000

 

-

 

-

 

-

 

 

 

-

 

9,000

Compensation-warrants/options 

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

21,524

 

(5,380)

 

-

 

16,144

Reclassification of derivative liabilities upon conversion of convertible debt

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

1,073,407

 

-

 

-

 

1,073,407

Net loss for the year ended March 31, 2016

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(5,351,060)

 

(5,351,060)

Balance March 31, 2016

 

-

 

-

 

264,503

 

26

 

319,768

 

32

 

998,236

 

3,461,300

 

1,221

 

66,917

 

9,880,912

 

(5,380)

 

(17,766,338)

 

(4,362,532)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for conversion of convertible debt and accrued interest

 

-

 

-

 

-

 

-

 

-

 

-

 

2,042,701,037

 

202,486

 

-

 

-

 

-

 

-

 

-

 

202,486

Stock -based compensation

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

5,380

 

-

 

5,380

Reclassification of derivative liabilities upon conversion of convertible debt

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

289,603

 

-

 

-

 

289,603

Shares issued for rounding in reverse split

 

-

 

-

 

-

 

-

 

-

 

-

 

4,499

 

-

 

-

 

-

 

-

 

-

 

-

 

-

Common stock issued for cinulting services

 

-

 

-

 

-

 

-

 

-

 

-

 

10,000,000

 

71,000

 

-

 

-

 

-

 

-

 

-

 

71,000

Net loss for the year ended March 31, 2017

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

(1,334,396)

 

(1,334,396)

Balance March 31, 2017

 

-

$

-

 

264,503

$

26

 

319,768

$

32

 

2,053,703,772

$

3,734,786

$

1,221

$

66,917

$

10,170,515

$

-

$

(19,100,734)

$

(5,128,459)

  

The accompanying notes are an integral part of these financial statements.

 

 
F-4
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

CONDENSED STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED MARCH 31,

 

 

 

 

 

 

 

 

2017

 

 

2016

 

CASH FLOWS FROM OPERATING ACTIVITIES 

 

 

 

 

 

 

Net loss

 

$ (1,334,396 )

 

$ (5,351,059 )

Adjustments to reconcile net loss to net cash used in operations: 

 

 

 

 

 

 

 

 

Amortization and depreciation 

 

 

29,090

 

 

 

32,165

 

Non-cash interest and fees

 

 

37,500

 

 

 

126,075

 

Loss on acquisition of assets from related party

 

 

-

 

 

 

1,044,817

 

Bad debt expense

 

 

2,270

 

 

 

82,522

 

Common stock and options issued for compensation 

 

 

5,380

 

 

 

16,144

 

Common stock issued for services 

 

 

71,000

 

 

 

9,000

 

Fair value of Series C preferred stock

 

 

-

 

 

 

208,951

 

Non-cash advertising expenses (barter)

 

 

23,625

 

 

 

-

 

Gain on extinguishment of debt

 

 

-

 

 

 

(4,096 )

Issuance of convertible notes for services

 

 

-

 

 

 

47,000

 

Amortization of debt discounts

 

 

633,732

 

 

 

1,186,654

 

(Gain) loss on fair value of derivatives

 

 

(67,603 )

 

 

942,280

 

Changes in operating assets and liabilities: 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

21,003

 

 

 

(231,985 )

Prepaid expenses  and other recevables

 

 

11,102

 

 

 

38,955

 

Accounts payable and accrued liabilities 

 

 

295,688

 

 

 

238,498

 

Accounts payable and accrued liabilities, related party

 

 

191,545

 

 

 

144,959

 

NET CASH USED IN OPERATING ACTIVITIES 

 

 

(80,065 )

 

 

(1,469,120 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES 

 

 

 

 

 

 

 

 

Purchase of property and computer equipment 

 

 

-

 

 

 

(280 )

Cash paid for acquisition of assets related party

 

 

-

 

 

 

(200,000 )

NET CASH USED IN INVESTING ACTIVITIES 

 

 

-

 

 

 

(200,280 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES 

 

 

 

 

 

 

 

 

Bank overdraft

 

 

820

 

 

 

-

 

Proceeds from note payable

 

 

-

 

 

 

310,600

 

Payments of principal on notes payable

 

 

(3,500 )

 

 

(95,451 )

Payments of principal on convertible notes payable 

 

 

(12,224 )

 

 

-

 

Payments to loan-related party

 

 

-

 

 

 

(51,512 )

Proceeds from issuance of convertible debt 

 

 

48,000

 

 

 

1,161,424

 

Proceeds from loan-related party 

 

 

31,850

 

 

 

156,512

 

NET CASH PROVIDED BY FINANCING ACTIVITIES 

 

 

64,946

 

 

 

1,481,573

 

 

 

 

 

 

 

 

 

 

NET DECREASE IN CASH AND CASH EQUIVALENTS 

 

 

(15,119 )

 

 

(187,827 )

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS 

 

 

 

 

 

 

 

 

Beginning of year

 

 

15,244

 

 

 

203,072

 

End of year

 

$ 125

 

 

$ 15,244

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

 

 

 

Cash paid for interest

 

$ 15,771

 

 

$ 23,918.00

 

Cash paid for income taxes

 

$ -

 

 

$ -

 

 

 

 

 

 

 

 

 

 

SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Shares issued in settlement of debt and interest on convertible debt 

 

$ 202,486

 

 

$ 575,719

 

Original issue discounts 

 

$ 5,739

 

 

$ 158,019

 

Original debt discount against derivative liabilities

 

$ 55,500

 

 

$ 1,262,085

 

Common stock issued to satisfy common stock to be issued

 

$ -

 

 

$ 55,480

 

Initial value of derivative liabilities 

 

$ 95,553

 

 

$ 2,234,601

 

Asset and intangibles purchased from related party with common stock

 

$ -

 

 

$ 740,000

 

Reclassification of derivatives upon conversion of convertible debt

 

$ 289,603

 

 

$ 1,073,407

 

Increase in convertible notes payable for additional interest 

 

$ 30,000

 

 

$ -

 

 

The accompanying notes are an integral part of these financial statements.

 

 
F-5
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

NOTE 1 - Nature of Operations 

 

Bravatek Solutions, Inc., a Colorado corporation (the “Company"), was incorporated on April 19, 2007. Effective September 29, 2015, the Company changed its name to "Bravatek Solutions, Inc." in order to better reflect the Company's expanding operations and strategy. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, hardware and services, and telecom services. Products include software, hardware and services, and span a diverse variety of industries including, but not limited to, email security, user authentication, telecommunications and cyber breach protection.

 

On May 31, 2016, the Company filed Articles of Amendment to increase the number of shares of common stock the corporation is authorized to issue to 10,000,000,000. 

 

On June 17, 2016, the Company affected a 1:2,500 reverse stock split on its’ shares common stock. The reverse stock split took effect on June 20, 2016. Share information included in the financial statements and notes thereto have been retroactively adjusted for the stock split as if such stock split occurred on the first day of the first period presented. Certain amounts in the notes to the financial statements may be slightly different than previously reported due to rounding of fractional shares as a result of the reverse stock split.

 

NOTE 2 - Significant Accounting Policies

 

Basis of Presentation 

 

The financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America ("U.S. GAAP").

 

Use of Estimates 

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. 

 

Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities. 

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term events. Accordingly, actual results could differ significantly from estimates. 

 

Fiscal Year

 

The Company's fiscal year-end is March 31. 

 

 
F-6
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Cash and Cash Equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less. The Company had no cash equivalents.

 

Sales Concentration and credit risk

 

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the years ended March 31, 2017, and 2016:

 

Customer

 

Sales % Year Ended

March 31, 2017

 

Sales % Year Ended

March 31, 2016

Customer A, related party

 

71.4%

 

-

Customer B, related party

 

-

 

32.2%

Customer C, related party

 

-

 

15.5%

Customer D

 

-

 

23.2%

Customer E

 

-

 

28.7%

 

There was no accounts receivable at March 31, 2017.

 

Accounts Receivable/Allowance for Doubtful Accounts

 

The Company records its client receivables and unbilled services at their face amounts less allowances. On a periodic basis, the Company evaluates its receivables and unbilled services and establishes allowances based on historical experience and other currently available information. As of March 31, 2017, and 2016, management determined there was no need to establish an allowance for doubtful accounts because there had been little history of nonpayment or indicators of credit risk, such as bankruptcy.

 

Property and Equipment

 

Property and equipment is stated at cost, less accumulated depreciation and is reviewed for impairment whenever occurrence of events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5-7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. 

 

Depreciation expense was $8,970 and $11,989 for the years ended March 31, 2017, and 2016, respectively.

 

Software Development Costs

 

Costs for software developed for internal use are accounted for through the capitalization of those costs incurred in connection with developing or obtaining internal-use software. Capitalized costs for internal-use software are included in intangible assets in the balance sheet. Capitalized software development costs are amortized over three years.

 

Costs incurred during the preliminary project along with post-implementation stages of internal use computer software development and costs incurred to maintain existing product offerings are expensed as incurred. The capitalization and ongoing assessment of recoverability of development costs require considerable judgment by management with respect to certain external factors, including, but not limited to, technological and economic feasibility and estimated economic life. During the years ended March 31, 2017, and 2016, the Company incurred no capitalized software development costs. Capitalized software is amortized over the software's estimated economic life of 3 years. For the years ended March 31, 2017, and 2016, amortization expense for capitalized software development was $20,121 and $20,176, respectively.

 

 
F-7
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Long-Lived Assets 

 

The Company reviews long-lived assets and certain identifiable intangibles held and used for possible impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In evaluating the fair value and future benefits of its intangible assets, management performs an analysis of the anticipated undiscounted future net cash flow of the individual assets over the remaining amortization period. The Company recognizes an impairment loss if the carrying value of the asset exceeds the expected future cash flows.

 

Income Taxes 

 

The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the "more likely than not" criteria of ASC 740. 

 

ASC 740-10 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the "more-likely-than-not" threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

Research and Development

 

Costs and expenses that can be clearly identified as research and development are charged to expense as incurred in accordance with GAAP. All research and development costs have been expensed as incurred, totaling $29,998 and $492,986 for the years ended March 31, 2017, and 2016, respectively.

 

Advertising and Promotion

 

The Company expenses advertising costs as incurred. Advertising expenses for the years ended March 31, 2017, and 2016, was $26,074 and $105,778, respectively. Advertising expenses of $23,625 for the year ended March 31, 2017, were the result of barter transactions, whereby, the Company received advertising and promotional services in exchange for sales of software.

 

Advertising and Revenue Barter Transactions

 

The Company recognized revenue and expense, in accordance with ASC 845 - Nonmonetary Transactions, at fair value only if the fair value of the advertising received is determinable based in the entity’s own historical practice of receiving cash or other consideration that is readily convertible to a known amount of cash for similar advertising from buyers unrelated to the Company. If the fair value of the advertising received is not determinable within these limits, the barter transaction would be recorded based on the carrying amount of the advertising received, which likely will be zero. The Company recorded barter transactions during the year ended March 31, 2017, based on the entity’s own historical practice of receiving cash or other consideration.

 

Uncertainty as a Going Concern 

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has an accumulated deficit of $19,100,734, and has a working capital deficit of $5,173,933 as of March 31, 2017, which raises substantial doubt about its ability to continue as a going concern. 

 

The Company's ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through a private placement and public offering of its common stock. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. 

 

 
F-8
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Fair Value of Financial Instruments

 

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. 

 

The following are the hierarchical levels of inputs to measure fair value: 

 

 

·

Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.

 

·

Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

·

Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

 

The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments. 

 

The following table represents the Company’s financial instruments that are measured at fair value on a recurring basis as of March 31, 2017, and 2016, for each fair value hierarchy level:

 

March 31, 2017

 

Derivative

Liabilities

 

 

Total

 

Level I

 

$ -

 

 

$ -

 

Level II

 

$ -

 

 

$ -

 

Level III

 

$ 1,654,015

 

 

$ 1,654,015

 

 

 

 

 

 

 

 

 

 

March 31, 2016

 

 

 

 

 

 

 

 

Level I

 

$ -

 

 

$ -

 

Level II

 

$ -

 

 

$ -

 

Level III

 

$ 1,955,721

 

 

$ 1,955,721

 

 

Embedded Conversion Features

 

The Company evaluates embedded conversion features within convertible debt under ASC 815 "Derivatives and Hedging" to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 "Debt with Conversion and Other Options" for consideration of any beneficial conversion feature. 

 

 
F-9
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Derivative Financial Instruments

 

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. 

 

For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. 

 

Debt Issue Costs and Debt Discount

 

The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs prior to maturity a proportionate share of the unamortized amounts is immediately expensed. 

 

Original Issue Discount

 

For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the initial carrying value of the note and is amortized to interest expense through the maturity of the debt. If a conversion of the underlying debt occurs prior to maturity a proportionate share of the unamortized amounts is immediately expensed. 

 

Extinguishments of Liabilities

 

The Company accounts for extinguishments of liabilities in accordance with ASC 860-10 (formerly SFAS 140) "Accounting for Transfers and Servicing of Financial Assets and Extinguishment of Liabilities." When the conditions are met for extinguishment accounting, the liabilities are derecognized and the gain or loss on the sale is recognized. 

 

Revenue Recognition

 

Product revenue and miscellaneous income are recognized as earned.

 

The Company recognizes revenue and gains when earned and related costs of sales and expenses when incurred. The Company recognizes revenue in accordance with Accounting Standards Codification Section 605-10-S99, Revenue Recognition, Overall, SEC Materials ("Section 605-10-S99"). Section 605-10-S99 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. The Company recognizes revenue from services at the time the services are completed. The Company’s sale of licensed software has significant standalone functionality with a perpetual right to use the Company’s intellectual property. Accordingly, the Company recognizes licensed software revenue at the time the software is delivered or available to the customer, at which time the company had no further obligations related to the sale of the software. Cost of products sold consists of the cost of the purchased goods and labor related to the corresponding sales transaction.

 

 
F-10
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Stock-Based Compensation – Employees

 

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.

 

The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: 

 

 

·

Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees' expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments. Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the actual method to calculate expected term of share options and similar instruments as the company does have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

 

 

 

 

·

Expected volatility of the entity's shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses its actual historical volatility over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

 

 

 

 

·

Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments. We expect and use zero rate.

 

 

 

 

·

Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

 

Generally, all forms of share-based payments, including stock option grants, warrants and restricted stock grants and stock appreciation rights are measured at their fair value on the awards' grant date, based on estimated number of awards that are ultimately expected to vest. The expense resulting from share-based payments is recorded in general and administrative expense in the statements of operations. 

 

 
F-11
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Stock-Based Compensation – Non-Employees

 

Equity Instruments Issued to Parties Other Than Employees for Acquiring Goods or Services

 

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Sub-topic 505-50 of the FASB Accounting Standards Codification ("Sub-topic 505-50"). 

 

Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.

 

The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: 

 

 

·

Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder's expected exercise behavior into the fair value (or calculated value) of the instruments. The Company uses historical data to estimate holder's expected exercise behavior.

 

 

 

 

·

Expected volatility of the entity's shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses its actual historical volatility over the expected contractual life of the share options or similar instruments as its expected volatility.

 

 

 

 

·

Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments. We expect and use zero rate.

 

 

 

 

·

Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

 

Pursuant to ASC paragraph 505-50-25-7, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic. 

 

 
F-12
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a share option and similar instrument that the counterparty has the right to exercise expires unexercised. 

 

Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded. 

 

Related Parties

 

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. 

 

Pursuant to Section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. 

 

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. 

 

Net Earnings (Loss) per Share 

 

Basic and diluted net loss per share information is presented under the requirements of ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, less shares subject to repurchase. Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, warrants and convertible notes in the weighted-average number of common shares outstanding for a period, if dilutive. For the years ended March 31, 2017, and 2016, there were warrants and options to purchase 3,365 shares of common stock and the Company’s outstanding convertible debt is convertible into approximately 22,762,118,935 and 8,095,224 shares of common stock, respectively. These amounts are not included in the computation of dilutive loss per share because their impact is antidilutive.

 

 
F-13
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Recent Accounting Pronouncements

 

On May 28, 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, requiring an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The updated standard will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either the retrospective or cumulative effect transition method. Early adoption is not permitted. The updated standard is effective for us in the first quarter of fiscal 2018. However, in April 2015, the FASB approved to defer the effective date by one year which we will evaluate if approved. Further, we have not yet selected a transition method and we are currently evaluating the effect that the updated standard will have on our consolidated financial statements and related disclosures.

 

On August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern, which requires management to evaluate, at each annual and interim reporting period, whether there are conditions or events that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date the financial statements are issued and to provide related disclosures. ASU 2014-15 is effective for us for our fiscal year ending March 31, 2017 and for interim periods thereafter.

 

With the exception of the new standard discussed above, there have been no other recent accounting pronouncements or changes in accounting pronouncements during the year ended March 31, 2017, as compared to the recent accounting pronouncements described in our Annual Report on Form 10-K for the fiscal year ended March 31, 2016, that are of significance or potential significance to us.

 

NOTE 3 - Related Party Activity

 

Asset Acquisition

 

On June 2, 2015, the Company completed an acquisition of certain of the assets and assumed certain liabilities of Viking Telecom Services, LLC (“Viking Telecom”) from Dependable Critical Infrastructure, Inc. (“DCI”), f/k/a DTREDS Consolidated, Inc., a related party due to the Company’s Chief Executive Officer (“CEO”) owned approximately 30% of DCI. To acquire the assets, the Company issued 2,265 shares of common stock, 224 shares of common stock to be issued (valued in the aggregate at $740,000), paid $200,000 cash and forgave $59,204 of a note receivable from DCI. The Company now provides telecom services under a new Viking Telecom brand. Services provided by Viking Telecom include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services. The Company recorded a loss on the acquisition of $1,044,817 for the year ended March 31, 2016.

 

Revenues

 

For the years ended March 31, 2017, and 2016, related party revenues were $145,362 and $186,837, respectively, representing revenues of 71.6% and 48.2%, respectively, for each period. For the year ended March 31, 2017, the related party was temporarily a related party based on the percentage of shares owned by management of the related party, of the issued and outstanding common stock of the Company at the time of the sales. The party is no longer a related party. For the year ended March 31, 2016, the Company recorded sales to three related party companies in the amounts of $126,148, $59,404 and $1,750, respectively. The sales of $1,750 were to a limited liability company controlled by our CEO.

 

Notes payable

 

The Company issued multiple unsecured notes payable from June 27, 2015, to March 31, 2017, to the Company’s CEO, for amounts advanced to the Company, or expenses paid by the CEO, on behalf of the Company., For the years ended March 31, 2017 and 2016, advances were $31,850 and $156,512, and the Company made repayments of $51,512 for the year ended March 31, 2016. The notes carry interest at 10% per annum and are due on demand. As of March 31, 2017, and 2016, the principal balance of the notes was $136,850 and $105,000, respectively, (included in note payable related party in the balance sheets presented herein), and included in accrued interest related party is the accrued and unpaid interest as of March 31, 2017, and 2016, of $23,153 and $11,550, respectively. For the years ended March 31, 2017, and 2016, the Company recorded interest expense related party of $11,603 and $11,550, respectively.

 

 
F-14
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

Management Fees

 

For the years ended March 31, 2017, and 2016, the Company recorded expenses to its officers in the following amounts:

 

 

 

Year Ended

March 31,

 

 

 

2017

 

 

2016

 

CEO

 

$ 140,000

 

 

$ 523,220

 

CFO

 

 

72,000

 

 

 

33,500

 

Total

 

$ 212,000

 

 

$ 556,720

 

 

Included in the year ended March 31, 2016, expenses are $217,220 for the fair value of the amendment to the Series C Preferred Stock, whereby each share of preferred stock has voting rights equal to 10,000 shares of common stock. As of March 31, 2017, included in accounts payable - related party is $248,692 and $37,750, for amounts owed the Company’s CEO and CFO, respectively, for unpaid fees and expenses.

 

NOTE 4 - Notes Payable

 

From May 18, 2010 through June 27, 2013, the Company issued in the aggregate $558,500 of unsecured notes payable to a Nevada corporation, lender and preferred shareholder of the Company ("Global"). The notes bear interest at 10%, compounded annually and $553,000 and $5,500 matured on November 30, 2014, and June 27, 2015, respectively. On February 16, 2015, the Company secured extensions on all of the notes that matured on November 30, 2014 through April 1, 2015, with no other changes in original terms of the agreement.

 

On June 15, 2015, the Company entered into a  Settlement Agreement and Partial Waiver and Release  (the "Settlement Agreement") with Global. Global owned 2,377,500 shares of the Company's Series A Convertible Preferred Stock, and is the holder of outstanding promissory notes in the original principal amount of $558,500, with accrued interest thereon due to Global of approximately $267,960 (the "Global Notes") immediately prior to the Settlement Agreement. Pursuant to the Settlement Agreement, Global agreed to (1) waive interest due of $267,960 under the Global Notes and forgive $158,500 of principal, such that only $400,000 of principal and interest would be considered outstanding as of the settlement agreement date, and (2) immediately return all of the Series A Convertible Preferred Stock to the Company for cancellation, in consideration for the Company issuing 856 shares of common stock to Global. Due to the related party nature at the time of the Settlement Agreement, the $238 balance in Series A Convertible Preferred Stock and the debt forgiveness was recorded as additional paid in capital. As of March 31, 2017 and 2016, the note balance was $400,000. As of June 15, 2015, the note is payable on demand as part of the Settlement Agreement. Accrued interest as of March 31, 2017, and 2016, was $40,110.

 

The Company issued five notes from December 18, 2012 to May 30, 2013 totaling $199,960 in unsecured notes payable to a third party. The notes bear an interest rate of 10%, compounded annually and matured from December 18, 2014 through May 30, 2015. On February 16, 2015, the Company secured a notes payable extension through April 1, 2015, with no other changes in original terms of the agreements. The notes payable were again extended on August 6, 2015, through January 1, 2016, with no other changes in original terms of the agreement. As of March 31, 2017, and 2016, the note balance was $199,960 and the notes are currently in default. Accrued interest as of March 31, 2017, and 2016, was $82,784 and $62,788, respectively.

 

The Company issued six notes from July 12, 2013 to June 16, 2014, totaling $230,828 in unsecured notes payable to a third party. The notes bear an interest rate of 10%, compounded annually and matured from July 12, 2014 through June 16, 2015. On February 16, 2015, the Company secured a notes payable extension through April 1, 2015, with no change in original terms of the agreements. The notes payable were again extended on August 6, 2015, through January 1, 2016, with no change in original terms of the agreements. As of March 31, 2017, and 2016 the note balance was $230,828 and the notes are currently in default Accrued interest as of March 31, 2017, and 2016, was $74,765 and $51,682, respectively

 

On June 2, 2015, as part of the Asset Purchase Agreement with DCI, the Company assumed limited liabilities associated with Viking (loan payment for Chevrolet truck in the amount of $668 per month with a principal balance of $36,202, and a loan payment to Joshua Claybaugh of $5,000 per month for 11 months for a total of $55,000). The Chevrolet truck loan was paid off as of March 31, 2016. As of March 31, 2017, and 2016, the loan with Joshua Claybaugh had a remaining principal balance of $20,000. There was no accrued interest as of March 31, 2017, and 2016.

 

 
F-15
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

The Company entered into a Senior Secured Credit Facility Agreement (the “Credit Agreement”) dated June 30, 2015 with TCA Global Credit Master Fund, LP (“TCA”) that was executed on June 30, 2015 and made effective as of November 25, 2015, which was to allow the Company to borrow up to $3,000,000. The Credit Agreement bears interest at 18%, compounded annually, and matured on January 25, 2017. The loan is secured against all existing and after-acquired tangible and intangible assets of the Company. On November 25, 2015, the Company received $310,600, net of loan costs and fees of $39,400. In connection with the Credit Agreement, the Company issued 1,412 shares of common stock upon execution, initially valued at $75,000 as an advisory fee payment (the “Advisory Fee”) and is obligated to issue additional shares until TCA has recouped $75,000 from the sale of the shares. The Company recorded the Advisory Fee and loan cost and fees of $114,400 as a discount to the TCA note and amortized the costs over the maturity of the note. Accordingly, for the years ended March 31, 2017, and 2016, the Company expensed $80,352 and $34,048, respectively, included in amortization of debt discount in the Statement of Operations presented herein. As of March 31, 2017, and 2016, the TCA loan had a principal balance of $319,662. Interest expense for the years ended March 31, 2017, and 2016, was $73,051 and $15,750, respectively. Accrued interest as of March 31, 2017, and 2016, was $58,169 and $0, respectively.

 

On September 6, 2016, TCA commenced an action against the Company and the Company’s CEO, Dr. Cellucci, as “validity guarantor,” filed in the Circuit Court of the 17 th  Judicial Circuit in and for Broward County, Florida, for amounts owed to TCA by the Company under their revolving credit agreement with the Company. On April 21, 2017, the Company, Dr. Cellucci and TCA executed a settlement agreement (the “Settlement Agreement”). Pursuant to the Settlement Agreement, the Company agreed to pay $2,500 by April 30, 2017, $2,500 by May 31, 2017 and $405,357 on or before June 16, 2017. The Company fully complied with its obligations under the settlement agreement, paying TCA all amounts owed thereunder within the times required, and the case has now been dismissed.

 

NOTE 5 - Convertible Notes Payable

 

The Company accounted for the conversion features embedded in the following Notes under ASC Topic 815-15 "Embedded Derivative." The derivative component of the obligation isinitially valued and classified as a derivative liability with an offset to discounts on convertible debt. Discounts are amortized to interest expense over the respective terms of the related notes. See Note 6.

 

On December 19, 2014, the Company issued a convertible note payable, with a face value of $156,000 and stated interest of 8% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, and based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion. For the year ended March 31, 2017, the investor converted a total of $12,380 of the face value and $2,332 of accrued interest into 6,593,919 shares of common stock. During the year ended March 31, 2016, the investor converted a total of $142,495 of the face value and $13,440 of accrued interest into 120,984 shares of common stock. For the year ended March 31, 2016, amortization of the debt discount of $89,462 was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $1,125 and $13,505, respectively.

 

On December 19, 2014, the Company issued a convertible back-end note, with a face value of $156,000 and stated interest of 8% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion. The note was funded on June 18, 2015, when the Company received proceeds of $143,333, net of $12,663 of OID and costs. For the year ended March 31, 2017, the investor converted a total of $24,300 of the face value and $4,146 of accrued interest into 373,844,490 shares of common stock. The embedded conversion feature included in the note resulted in an initial debt discount of $150,000, an initial derivative expense of $84,000 and an initial derivative liability of $234,000. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $32,055 and $117,945, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $131,700 and $156,000, respectively.

 

On December 19, 2014, the Company issued a convertible note payable, with a face value of $156,000 and stated interest of 8% to a third-party investor. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion. For the year ended March 31, 2017, the investor had converted a total of $12,543 of the face value into 102,692,184 shares of common stock. During the year ended March 31, 2016, the investor converted a total of $97,500 of the face value into 247,818 shares of common stock. For the year ended March 31, 2016, amortization of the debt discount of $89,462 was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $45,957 and $58,500, respectively.

 

On December 19, 2014, the Company issued a convertible back-end note, with a face value of $156,000 and stated interest of 8% to a third-party investor. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion. The note was funded on June 18, 2015, when the Company received proceeds of $143,333, net of $12,663 of OID and costs The embedded conversion feature included in the note resulted in an initial debt discount of $150,000, an initial derivative expense of $84,000 and an initial derivative liability of $234,000. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $32,055 and $117,945, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $156,000.

 

 
F-16
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On January 11, 2015, the Company entered in to a securities purchase agreement providing for the issuance of two convertible promissory notes in the principal amount of $52,000 each. One of the notes was funded on January 13, 2015, with the Company receiving $47,500 of net proceeds after payment of legal and origination expenses. The note bears interest at the rate of 8% per annum, is due and payable on January 9, 2015, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to 67% of the lowest closing bid price on the OTCQB during the 15 prior trading days. The second note, which was funded on August 7, 2015, has the same interest and conversion terms as the first note. The embedded conversion feature included in the second note resulted in an initial debt discount of $50,000, an initial derivative expense of $45,000 and an initial derivative liability of $95,000. For the year ended March 31, 2016, amortization of the debt discount of $86,471 was charged to interest expense. During the year ended March 31, 2017, the investor converted a total of $32,094 of the face value of the second note and $4,154 of accrued interest into 308,572,080 shares of common stock. During the year ended March 31, 2016, the investor converted a total of $52,000 of the face value of the first note and $3,357 of accrued interest into 82,604 shares of common stock. As of March 31, 2017, and 2016, the outstanding principal amount of the second note was $19,906 and $52,000, respectively.

 

On January 19, 2015, the Company issued a convertible promissory note in the face amount of $100,000, which bears interest at the rate of 12% per annum, is due and payable on July 16, 2015, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to the lesser of (a) 55% of the lowest trading price during the 20 days preceding the execution of the note, or (b) 55% of the of the lowest traded price during the 20 trading days preceding conversion. The note was funded on January 28, 2015, with the Company receiving $93,000 of net proceeds after payment of legal and origination expenses. During the year ended March 31, 2017, the investor converted a total of $24,403 of the face value into 282,194,706 shares of common stock. During the year ended March 31, 2016, the investor converted a total of $41,177 of the face value into 202,075 shares of common stock. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $35,732 and $54,214, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $34,420 and $58,823, respectively.

 

On January 21, 2015, the Company issued a convertible promissory note in the face amount of $400,000, of which the Company is to assume $40,000 in original interest discount ("OID"), which together with any unpaid accrued interest is due two years after any funding of the note. The note is to be funded at the note holder's discretion, and the initial tranche was funded on January 21, 2015, when the Company received cash in the amount of $50,000, and received an additional $25,000 (the “Second Funding”) on April 28, 2015. The note is pre-payable for 90 days without interest, and incurs a one-time interest charge of 12% thereafter. The note balance funded (plus a pro rata portion of the OID together with any unpaid accrued interest) is convertible into shares of Company common stock at a conversion price equal to the lesser of $0.08 or 60% of the lowest traded price during the 25 prior trading days. During the year ended March 31, 2016, the investor converted a total of $67,885 of the face value and $6,667 of accrued interest into 115,055 shares of common stock. The embedded conversion feature included in the Second Funding resulted in an initial debt discount of $25,000, an initial derivative expense of $26,000 and an initial derivative liability of $51,000. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $29,635 and $45,221, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $15,480.

 

On February 3, 2015, the Company issued a collateralized secured convertible promissory for a 10% convertible promissory note with an aggregate principal amount of $252,500, of which the company is to assume an OID of $22,500 and legal fees and other expenses totaling $5,000, which together with any unpaid accrued interest was due on November 3, 2015. The note is to be issued in tranches with an initial tranche of $87,500, of which the company received $75,000 on February 6, 2015, with the remaining $5,000 being used for legal and other expenses and the Company assuming $7,500 of the OID. This convertible note together with any unpaid accrued interest is convertible into shares of Company common stock at a conversion price equal to the 60% of the average of the lowest three closing bid prices during the 20 prior trading days. The remaining three tranches, which have not yet been funded, of $55,000 under the note will consist of $50,000 in principal and $5,000 of the OID, and may be offset by three $50,000 promissory notes issued in favor of the Company, accruing interest at 8% per annum and maturing on November 3, 2015. In conjunction with the convertible note issued by the Company and the three promissory notes issued to the Company for the three additional tranches of funding to the Company, the Company issued four warrants for a total number of shares equal to $123,750 ($41,250 for the first warrant corresponding to funding on February 6, 2015, and $27,500 for the other three warrants corresponding to the future tranches of funding to the Company) divided by the conversion market price in the convertible note. The warrants have an exercise price of $0.10, subject to adjustment, and expire on January 3, 2020. Each of the warrants is only exercisable after the corresponding tranche of funding to the Company has been paid.

 

Therefore, the first warrant is currently exercisable, but the other three warrants are not. On or about September 17, 2015, the company added $27,832 in principal and $3,333 of fees as part of a true up add back (the “True Up”). During the year ended March 31, 2016, the investor converted a total of $71,853 of the face value and $5,383 of accrued interest into 2,808 shares of common stock. The embedded conversion feature included in the True Up resulted in an initial debt discount of $27,832, an initial derivative expense of $11,168 and an initial derivative liability of $39,000. For the year ended March 31, 2016, amortization of the debt discount of $94,734 was charged to interest expense. On November 12, 2015, the investor sold the note and the Company issued a replacement note of $47,808, as described below.

 

On April 10, 2015, the Company issued a convertible note, with a face value of $105,000, of which the company was to assume an OID of $5,000, and stated interest of 10% to a third-party investor. The outstanding balance of this note was convertible into a variable number of the Company's common stock, based on a conversion ratio of 65% of the lowest closing bid prices for 15 days prior to conversion. The embedded conversion feature included in the note resulted in an initial debt discount of $100,000, an initial derivative expense of $65,000 and an initial derivative liability of $165,000. For the years ended March 31, 2016, amortization of the debt discount of $100,000 was charged to interest expense. On October 12, 2015, the investor sold the note and the Company issued a replacement note of $110,351, as described below. 

 

 
F-17
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On August 17, 2015, the Company issued a convertible promissory note in the face amount of $325,000, which bears interest at the rate of 10% per annum, was due and payable on August 17, 2016, and may be converted at any time after funding into shares of Company common stock at a conversion price equals the lesser of $.02 or 70% of the closing trading prices immediately preceding the conversion date. In conjunction with the convertible note issued by the Company, the Company issued 2,064 warrants valued at $412,698. The warrants have an exercise price of $270, subject to adjustment, and expire on August 17, 2020. During the year ended March 31, 2017, the Company and the noteholder agreed to add $30,000 to the principal balance of the note in exchange for the noteholder’s waiver of Liquidated Damages as defined in the note. During the year ended March 31, 2017, the investor converted $29,741 of accrued interest into 435,574,242 shares of common stock. The embedded conversion feature included in the note resulted in an initial debt discount and derivative liability of $139,286. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $52,661 and $86,624, respectively was charged to interest expense. The embedded conversion feature included in the warrant resulted in an initial debt discount and derivative liability of $181,818. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $36,364 and $113,076, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $355,000 and $325,000, respectively.

 

On October 12, 2015, the Company issued a replacement convertible promissory note in the face amount of $110,351, to Carebourn Capital, LLC (“Carebourn”) that replaced the convertible promissory note issued on April 10, 2015, with a face value of $105,000, and accrued interest of $5,351. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note also bears an interest rate of 10% per annum. During the year ended March 31, 2017, Carebourn converted a total of $24,308 of the face value into 189,121 shares of common stock. During the year ended March 31, 2016, Carebourn converted a total of $61,043 of the face value into 189,121 shares of common stock. Additionally, on January 19, 2016, Carebourn assigned $10,000 of the note to Carebourn Partners, LLC (“Carebourn Partners”). As of March 31, 2017, and 2016, the outstanding principal amount of the note was $-0- and $34,308, respectively.

 

Also on October 12, 2015, Carebourn and the Company assigned $15,000 of the replacement issued to Carebourn, to More Capital. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note also bears an interest rate of 10% per annum. During the year ended March 31, 2016, the investor converted a total of $12,950 of the face value into 28,726 shares of common stock. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $2,050.

 

On October 26, 2015, the Company issued a convertible note, with a face value of $110,000 and stated interest of 10% to a third-party investor, of which the company was to assume an OID of $10,000. The outstanding balance of this note was convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the lowest average of the three lowest closing bid prices for 20 days prior to conversion. The embedded conversion feature included in the note resulted in an initial debt discount of $100,000, an initial derivative expense of $149,496 and an initial derivative liability of $249,496. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $42,700 and $57,300, respectively, was charged to interest expense. The investor sold $25,000 of the note on April 27, 2016, and the Company issued a replacement note to the buyer, as described below. On June 7, 2016, the Company and the third-party investor agreed to extend the maturity of the note from July 26, 2016, to October 26, 2016, and to require daily payments of $250 per day via ACH. For the year ended March 31, 2017, the Company paid $6,003 of the note. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $78,997.

 

On October 27, 2015, the Company issued a convertible note, with a face value of $110,000 and stated interest of 8% to a third-party investor, of which the company was to assume an OID of $10,000. The outstanding balance of this note was convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the lowest average of the three lowest closing bid prices for 20 days prior to conversion. The embedded conversion feature included in the note resulted in an initial debt discount of $100,000, an initial derivative expense of $102,000 and an initial derivative liability of $202,000. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $57,377 and $42,623, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $110,000.

 

On November 12, 2015, the Company issued a replacement convertible promissory note in the face amount of $47,808, to Carebourn that replaces the collateralized secured convertible promissory issued on February 3, 2015, that had a remaining face value of $43,479 and accrued interest of $4,326. The replacement note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note also bears an interest rate of 10% per annum. During the year ended March 31, 2017, the investor converted a total of $5,445 of the face value into 90,748,151 shares of common stock. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $42,363 and $47,808, respectively.

 

 
F-18
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On November 27, 2015, the Company issued a convertible note for legal services previously provided with a face value of $27,000 and stated interest of 10% to a third-party investor. The note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 70% of the average of the three lowest closing bid prices for 10 days prior to conversion. The embedded conversion feature included in the note resulted in an initial debt discount of $25,000, an initial derivative expense of $851 and an initial derivative liability of $25,851. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $4,808 and $20,192, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $27,000.

 

On January 5, 2016, the Company issued a convertible note for legal services previously provided with a face value of $20,000 and stated interest of 10% to a third-party investor. The note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 70% of the average of the three lowest closing bid prices for 10 days prior to conversion. The embedded conversion feature included in the note resulted in an initial debt discount and derivative liability of $19,149. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $10,101 and $9,048, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $20,000.

 

On January 19, 2016, Carebourn assigned $10,000 of the October 12, 2015, replacement note to Carebourn Partners, LLC (“Carebourn Partners”). As of March 31, 2017, and 2016, the outstanding principal amount of the replacement note was $10,000.

 

On February 4, 2016, the Company issued a convertible note, with a face value of $82,500 and stated interest of 8% to a third-party investor, of which the Company assumed an OID of $7,500, and stated interest of 8% to a third-party investor. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The embedded conversion feature included in the note resulted in an initial debt discount of $80,000, an initial derivative expense of $70,000 and an initial derivative liability of $150,000. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $67,760 and $12,240, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $82,500.

 

On February 8, 2016, the Company issued a convertible note, with a face value of $80,000 and stated interest of 10% to a third-party investor, of which the Company assumed an original issue discount of $5,000. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion and a maturity date of November 8, 2016. The embedded conversion feature included in the note resulted in an initial debt discount of $80,000, an initial derivative expense of $67,009 and an initial derivative liability of $147,009. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $64,818 and $15,182, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $80,000.

 

On March 24, 2016, the Company issued a convertible note, with a face value of $19,000 and stated interest of 10% to a third-party investor, of which the Company received $16,000 in proceeds. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion and a maturity date of December 24, 2016. The embedded conversion feature included in the note resulted in an initial debt discount of $19,000, an initial derivative expense of $15,915 and an initial derivative liability of $34,915. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $18,516 and $484, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $19,000.

 

On March 24, 2016, the Company issued a convertible note, with a face value of $18,000 and stated interest of 10% to a third-party investor, of which the Company received $15,000 in proceeds. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion and a maturity date of December 24, 2016. The embedded conversion feature included in the note resulted in an initial debt discount of $15,000, an initial derivative expense of $18,077 and an initial derivative liability of $33,077. For the years ended March 31, 2017, and 2016, amortization of the debt discount of $14,618 and $382, respectively, was charged to interest expense. As of March 31, 2017, and 2016, the outstanding principal amount of the note was $18,000.

 

On April 11, 2016, the Company issued a convertible note, with a face value of $18,889 and stated interest of 10% to a third-party investor. The note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The Company received net proceeds of $13,000 on April 28, 2016, after disbursements for the lender’s transaction costs, fees, and expenses. The embedded conversion feature included in the note resulted in an initial debt discount of $18,889 an initial derivative expense of $9,991 and an initial derivative liability of $28,880. For the year ended March 31, 2017, amortization of the debt discount of $18,889 was charged to interest expense. As of March 31, 2017, the outstanding principal amount of the note was $18,889.

 

 
F-19
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On April 11, 2016, the Company issued a replacement convertible promissory note in the face amount of $26,123, to a third-party investor that replaces part of the convertible promissory note issued on October 26, 2015, with a face value of $25,000, and accrued interest of $1,123. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note also bears an interest rate of 10% per annum. During the year ended March 31, 2017, the investor converted a total of $19,476 of the face value and $3,332 of accrued interest and fees into 356,215,238 shares of common stock. As of March 31, 2017, the outstanding principal amount of the replacement note was $6,647.

 

On June 3, 2016, the Company issued a convertible note, with a face value of $42,350 and stated interest of 12% to a third-party investor. The note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The Company received proceeds on June 3, 2016, of $35,000, after disbursements for the lender’s transaction costs, fees, and expenses. The embedded conversion feature included in the note resulted in an initial debt discount of $42,350, an initial derivative liability expense of $24,323 and an initial derivative liability of $66,673. The note also requires 177 daily payments of $239 per day via ACH. For the year ended March 31, 2017, amortization of the debt discount of $35,292 was charged to interest expense. For the year ended March 31, 2017, the Company paid $6,221 of the note. The balance of the note as of March 31, 2017, was $36,129.

 

A summary of the convertible notes payable balance as of March 31, 2017, and 2016 is as follows:

 

 

 

March 31,

2017

 

 

March 31,

2016

 

Principal Balance

 

$ 1,311,163

 

 

$ 1,385,974

 

Unamortized discount

 

 

(39,436 )

 

 

(531,578 )

Ending Balance, net

 

$ 1,271,727

 

 

$ 854,396

 

 

The following is a roll-forward of the Company’s convertible notes and related discounts for the years ended March 31, 2017, and 2016:

 

 

 

Principal

Balance

 

 

Debt

Discounts

 

 

Total

 

Balance April 1, 2015

 

$ 603,723

 

 

$ (422,099 )

 

$ 181,624

 

New issuances

 

 

1,329,123

 

 

 

(1,262,085 )

 

 

67,038

 

Conversions

 

 

(546,872 )

 

 

-

 

 

 

(546,872 )

Amortization

 

 

-

 

 

 

1,152,606

 

 

 

1,152,606

 

Balance March 31, 2016

 

 

1,385,974

 

 

 

(531,578 )

 

 

854,396

 

New issuances

 

 

62,362

 

 

 

(61,239 )

 

 

1,123

 

Liquidated damages added to note

 

 

30,000

 

 

 

-

 

 

 

30,000

 

Conversions

 

 

(154,949 )

 

 

-

 

 

 

(154,949 )

Cash payments

 

 

(12,224 )

 

 

-

 

 

 

(12,224 )

Amortization

 

 

-

 

 

 

553,381

 

 

 

553,381

 

Balance at March 31, 2017

 

$ 1,311,163

 

 

$ (39,436 )

 

$ 1,271,727

 

 

NOTE 6 - Derivative liabilities

 

The Company determined that the conversion features of the convertible notes represented embedded derivatives since the Notes are convertible into a variable number of shares upon conversion. Accordingly, the notes are not considered to be conventional debt under EITF 00-19 and the embedded conversion feature is bifurcated from the debt host and accounted for as a derivative liability. Accordingly, the fair value of these derivative instruments are recorded as liabilities on the consolidated balance sheet with the corresponding amount recorded as a discount to each Note, with any excess of the fair value of the derivative component over the face amount of the note recorded as an expense on the issue date. Such discounts are amortized from the date of issuance to the maturity dates of the Notes. The change in the fair value of the derivative liabilities are recorded in other income or expenses in the condensed consolidated statements of operations at the end of each period, with the offset to the derivative liabilities on the balance sheet. See Note 5.

 

The Company valued the derivative liabilities at March 31, 2017, and 2016, at $1,645,015 and $1,955,721, respectively. The Company used the Monte Carlo simulation valuation model with the following assumptions for the year ended March 31, 2017; a risk-free interest rate of .76% and volatility of 225%. The assumptions used in the Monte Carlo simulation valuation for the year ended March 31, 2016 were; a risk free interest rate of 1.5% and a volatility of 300%.

 

 
F-20
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

A summary of the activity related to derivative liabilities for the year ended on March 31, 2017, and 2016, is as follows:

 

 

 

2017

 

 

2016

 

Beginning Balance

 

$ 1,955,721

 

 

$ 824,763

 

Initial Derivative Liability

 

 

95,553

 

 

 

2,049,004

 

Reclassification for note conversions

 

 

(289,603 )

 

 

(1,073,408 )

Fair Value Change

 

 

(107,656 )

 

 

155,362

 

Ending Balance

 

$ 1,654,015

 

 

$ 1,955,721

 

 

For the year ended March 31, 2017, the Company recorded a net credit to derivative expense of $67,603 consisting of the initial derivative expense of $40,053 and the above fair value change of $107,656. For the year ended March 31, 2016, derivative expense of $942,280 was comprised of the initial derivative expense of $786,918 and the above fair value change of $155,362.

 

NOTE 7 - Stockholders' Deficit

 

Common stock

 

On May 31, 2016, the registrant filed Articles of Amendment to increase the number of shares of common stock the corporation is authorized to issue to 10,000,000,000. 

 

On June 17, 2016, the Financial Industry Regulatory Authority ("FINRA") announced the registrant's 1:2,500 reverse stock split of the registrant's common stock. The reverse stock split took effect on June 20, 2016. Share information included in the financial statements and notes thereto have been retroactively adjusted for the stock split as if such stock split occurred on the first day of the first period presented. Certain amounts in the notes to the financial statements may be slightly different than previously reported due to rounding of fractional shares as a result of the reverse stock split.

 

As of March 31, 2017, and 2016, there were 2,053,703,772 and 998,236 shares of common stock issued and outstanding, respectively, and 1,221 shares of common stock to be issued.

 

During the year ended March 31, 2017, the Company issued 2,042,701,037 shares of common stock for conversion of $154,949 of principal and $47,537 of accrued interest, for a total of $202,486 and 4,499 shares were issued for rounding up in the reverse split

 

On August 1, 2016, the Company entered into a consulting agreement with YKTG, LLC ("YKTG"), pursuant to which YKTG would, in consideration of the issuance of 10,000,000 shares of Company common stock, assist in the selection and management of subcontractors for new and forthcoming POs from major telecom carries (Verizon, Sprint, AT&T, etc.), offer PMO skills, systems, tools, and advice to the Company and the Company's strategic alliance partners, provide sales personnel and management to assist the Company with obtaining additional telecom purchase orders, provide sales leads for government telecom applications, assist the Company to drive sales for its existing indefinite delivery/indefinite quantity ("IDIQ") contracts, and assist the Company in updating its five-year strategic business plan. On August 3, 2016, the Company issued the 10,000,000 shares to YKTG. The Company valued the shares at $0.0071 per share (the market price on the date of the consulting agreement), and recorded stock compensation expense of $71,000 for the year ended March 31, 2017, as no further services were expected to be performed after March 31, 2017.

 

During the year ended March 31, 2016, the Company issued 989,180 shares of common stock for conversion of $546,872 of principal and $28,847of accrued interest, for a total of $575,719.

 

In connection with the TCA Credit Agreement (See Note 4), the Company issued 1,412 shares of common stock, initially valued at $75,000 as an advisory fee payment (the “Advisory Fee”) and was obligated to issue additional shares until TCA has recouped $75,000 from the sale of the shares. The Company recorded the Advisory Fee and loan cost and fees of $114,400 as a discount to the TCA note and amortized the costs over the maturity of the note. Accordingly, for the years ended March 31, 2017, and 2016, the Company expensed $80,352 and $34,048, respectively, included in amortization of debt discount in the Statement of Operations presented herein.

 

During the year ended year ended March 31, 2016, the Company issued 59 shares of common stock for the shares of common stock to be issued that were to be issued as of March 31, 2015. The shares were valued at $55,480.

 

During the year ended year ended March 31, 2016, the Company issued 14 shares of common stock in exchange for legal services valued at $9,000.

 

 
F-21
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On June 15, 2015, the Company issued 856 shares of common stock to Global pursuant to a settlement agreement. Due to the related party nature at the time of the Settlement Agreement, the $238 balance in Series A Convertible Preferred Stock and the debt forgiveness (see Note 3) was recorded as additional paid in capital.

 

On July 9, 2015, the Company issued 1,208 shares of common stock and reserved 224 shares of common stock to be issued, and issued 264,503 shares of Series B Preferred Stock to the owners of DCI, pursuant to the Asset Purchase Agreement (see below).

 

On July 20, 2015, the Company pursuant to a Settlement Agreement (the "Micro-Tech Settlement Agreement") with Micro-Tech Industries, Ltd., a lender and preferred shareholder of the Company ("Micro-Tech"). Micro-Tech owned 839,500 shares of the Company's shares of Series A Convertible Preferred Stock. Pursuant to the Micro-Tech Settlement Agreement, Micro-Tech agreed to immediately return the 839,500 shares of Series A Preferred Stock to the Company for cancellation and the Company agreed to issue 319 shares of common stock to Micro-Tech. The Company debited the par value of the Series A preferred stock of $84, with the offset to common stock to be issued. As of the date of this report Micro-Tech has not returned the Series A Preferred Stock and the Company has not certificated and delivered the 319 shares of common stock. As of March 31, 2017, and 2016, the Company has included 319 shares as common stock to be issued.

 

Also on July 20, 2015, the Company entered into a Settlement Agreement (the "Whonon Settlement Agreement") with Whonon Trading S. A., lender and preferred shareholder of the Company ("Whonon"). Whonon owned 1,783,000 shares of the Company's shares of Series A Convertible Preferred Stock. Pursuant to the Whonon Settlement Agreement, Whonon agreed to immediately return the 1,783,000 shares of Series A Preferred Stock to the Company for cancellation and the Company agreed to issue 678 shares of common stock to Whonon. The Company debited the par value of the Series A preferred stock of $178, with the offset to common stock to be issued. As of the date of this report Micro-Tech has not returned the Series A Preferred Stock and the Company has not certificated and delivered the 319 shares of common stock. As of March 31, 2017, and 2016, the Company has included 997 shares as common stock to be issued.

 

During the year ended March 31, 2016, the Company's CEO and another shareholder returned a total of 1,279 shares of common stock to the Company for cancellation in exchange for the issuance of 319,768 shares of Series C Preferred Stock.

 

During the year ended March 31, 2016, 347 shares were issued for rounding up in the reverse split.

 

Preferred Stock

 

10,000,000 shares of preferred stock, $0.0001 par value have been authorized.

 

Series A Convertible Preferred Stock .

 

5,000,000 shares of preferred stock are designated as Series A Convertible Preferred Stock (“Series A Preferred Stock”). Each share of Series A Convertible Preferred Stock is convertible at the election of the holder into 0.004 shares of common stock, subject to a 4.9% beneficial ownership limitation, but has no voting rights until converted into common stock. In the event of any liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary, the holders of the outstanding shares of Series A Convertible Preferred Stock shall be entitled to be paid out of the assets of the Corporation available for distribution to its shareholders, whether from capital, surplus funds or earnings, and before any payment is made in respect of the shares of Common Stock, an amount equal to $2.50 per share of Series A Convertible Preferred Stock, subject to adjustment for stock dividends, combinations, splits, recapitalizations and the like with respect to the Series A Convertible Preferred Stock, plus any and all accrued but unpaid dividends. The holders of Series A Convertible Preferred Stock are entitled to dividends when declared by the board of directors. As of March 31, 2017, and 2016, there are no shares of Series A Preferred Stock outstanding.

 

On June 15, 2015, pursuant to the Settlement Agreement with Global (see Note 3), Global returned 2,377,500 shares of Series A Convertible Preferred Stock to the Company and the Company issued 856 shares of common stock to Global. Due to the related party nature at the time of the Settlement Agreement, the $238 balance in Series A Convertible Preferred Stock and the debt forgiveness was recorded as additional paid in capital.

 

 
F-22
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On July 20, 2015, pursuant to the Micro-Tech Settlement Agreement, Micro-Tech agreed to immediately return 839,500 shares of Series A Preferred Stock they owned to the Company for cancellation and the Company agreed to issue 319 shares of common stock to Micro-Tech.

 

Also on July 20, 2015, pursuant to the Whonon Settlement Agreement, Whonon agreed to immediately return the 1,783,000 shares of Series A Preferred Stock they owned to the Company for cancellation and the Company agreed to issue 678 shares of common stock to Whonon.

 

Series B Preferred Stock

 

350,000 shares of preferred stock are designated as Series B Preferred Stock. Each share of Series B Preferred Stock is convertible at the election of the holder into .004 shares of common stock, subject to a 4.9% beneficial ownership limitation. Series B Preferred Stock has no voting rights until converted into common stock. The holders of the Series B Preferred Stock do not have any rights to dividends or any liquidation preferences. As of March 31, 2017, and 2016, there are 264,503 shares of Series B Preferred Stock outstanding.

 

On June 2, 2015, the Company entered into an Asset Purchase Agreement with Dependable Critical Infrastructure, Inc., f/k/a DTREDS Consolidated Inc., a Delaware corporation ("DCI"), a related party due to the Company’s Chief Executive Officer (“CEO”) owned approximately 30% of DCI, and Viking Telecom Services, LLC, a Minnesota limited liability company ("Viking"). Pursuant to the Agreement, the parties agreed that the Company would purchase assets of DCI relating to Viking which DCI had acquired from Viking (general intangibles, including contract rights, office furniture totaling $7,392, IBM server, 2011 Chevrolet Silverado 2500 Diesel truck for $35,608, and accounts receivable after January 1, 2015 totaling $0), in consideration of the Company (1) assuming limited liabilities associated with Viking (loan payment for Chevrolet truck with a principal balance of $36,202, loan payment to a third party of $5,000 per month for 11 months totaling $55,000), (2) issuing the owners of DCI a total of 2,489 shares of Company common stock valued at $740,000, and (3) paying DCI $200,000, which was paid on June 19, 2015, and an initial deposit of $59,204. Since the Company’s CEO owned approximately 30% of DCI, the Company recorded a loss on the acquisition of $1,044,817 for the year ended March 31, 2016. On July 9, 2015, the Company issued 1,208 shares of common stock, reserved 224 shares of common stock and issued 264,503 shares of Series B Preferred Stock to the owners of DCI, in lieu of 1,048 shares of common stock. The shares of Series B Preferred Stock are convertible into 1,048 shares of common stock (ignoring the 4.9% conversion limitation in the Series B designation of rights). The 224 shares reserved for issuance are included in common stock to be issued as of March 31, 2017, and 2016.

 

Series C Preferred Stock

 

1,000,000 shares of preferred stock are designated as Series C Preferred Stock. Each share of Series C Preferred stock is convertible at the election of the holder into 100 shares of common stock. On October 23, 2015, (the “Amendment Date”), the Company amended the terms and conditions of the Series C Preferred stock, whereby each share of Series C Preferred stock entitles the holder thereof to 10,000 votes (the “Voting Rights”) on all matters submitted to a vote of the stockholders of the Company. The holders of the Series C Preferred stock do not have any rights to dividends or any liquidation preferences. During the year ended March 31, 2016, the Company's CEO and another shareholder returned a total of 1,279 shares of common stock to the Company for cancellation in exchange for the issuance of 319,768 shares of Series C Preferred Stock. As of March 31, 2017, there are 319,768 shares of Series C preferred stock outstanding, of which 223,768 shares are owned by our Chairman and CEO, Dr. Thomas Cellucci. The Company determined that on the Amendment Date, the amended voting rights of the preferred stock resulted in a change of control of the Company. The Company determined that the excess of the fair value of the Series C Preferred Stock over the value of the common stock, for the 223,768 shares issued to the Company’s CEO was $208,951. The Company determined that the fair value of the other 96,000 shares of Series C Preferred Stock did not exceed the fair value of the associated returned common stock. The fair value was determined as set forth in the Statement of Financial Accounting Standard ASC 820-10-35-37, Fair Value in Financial Instruments and incorporated the Voting Rights which had increased to approximately 64%

 

Stock Options

 

On July 23, 2015 (the “Grant Date”), the Company granted non-qualified stock options to two of its directors as compensation for their services. The directors are entitled to purchase a total of thirty (30) shares each of restricted common stock for a price equal to $250.00 per share (Exercise Price), exercisable over a ten-year period thereafter. The option shall be vested during the 12-month period. As to the total number of Shares with respect to which the Option is granted, the Option shall be exercisable as follows: (i) 25% of the Option in the aggregate may be exercised upon the mutual execution of this Agreement (ii) 50% of the Option in the aggregate may be exercised on or after the four month anniversary of the Grant Date; (iii) 75% of the Option in the aggregate may be exercised on or after the eight month anniversary of the Grant Date; and (iv) 100% of the Option in the aggregate may be exercised on or after the twelve month anniversary of the Grant Date (the twelve month period commencing on the Grant Date and ending on the twelve month anniversary of the Grant Date being referred to as the "Vesting Period"). As of March 31, 2017, none of the options have been exercised. The total fair value of these options at the date of grant was estimated to be $15,750 and was determined using the Black-Scholes option pricing model with an expected life of 10 years, a risk-free interest rate of 2.28%, a dividend yield of 0% and expected volatility of 230.55%. For the years ended March 31, 2017, and 2016, the Company has included $3,937 and $11,813, respectively, as stock based compensation expense based on the period when options vested.

 

 
F-23
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On August 26, 2015 (the “Grant Date”), the Company granted non-qualified stock options to a member of its board of directors as compensation for his services. The director is entitled to purchase a total of thirty (30) shares of restricted common stock for a price equal to $250.00 per share (Exercise Price), exercisable over a ten-year period thereafter. The option shall be vested during the 12-month period. As to the total number of Shares with respect to which the Option is granted, the Option shall be exercisable as follows: (i) 25% of the Option in the aggregate may be exercised upon the mutual execution of this Agreement (ii) 50% of the Option in the aggregate may be exercised on or after the four month anniversary of the Grant Date; (iii) 75% of the Option in the aggregate may be exercised on or after the eight month anniversary of the Grant Date; and (iv) 100% of the Option in the aggregate may be exercised on or after the twelve month anniversary of the Grant Date (the twelve month period commencing on the Grant Date and ending on the twelve month anniversary of the Grant Date being referred to as the "Vesting Period"). As of March 31, 2017, none of the options have been exercised. The total fair value of these options at the date of grant was estimated to be $5,775 and was determined using the Black-Scholes option pricing model with an expected life of 10 years, a risk-free interest rate of 2.18%, a dividend yield of 0% and expected volatility of 230.25%. For the year ending March 31, 2017, and 2016, the Company has included $1,444 and $4,331, respectively, as stock based compensation expense.

 

The following table summarizes activities related to stock options of the Company for the years ended March 31, 2017, and 2016:

 

 

 

Number of

Options

 

 

Weighted-Average Exercise Price per share

 

 

Weighted-Average Remaining Life (Years)

 

Outstanding April 1, 2015

 

 

12

 

 

$ 7,500

 

 

 

6.88

 

Granted

 

 

90

 

 

 

250

 

 

 

10.0

 

Outstanding at March 31, 2016

 

 

102

 

 

$ 1,102.94

 

 

 

8.94

 

Exercisable at March 31, 2016

 

 

80

 

 

 

1,337.50

 

 

 

 

 

Outstanding and exercisable at March 31, 2017

 

 

102

 

 

$ 1,102.94

 

 

 

7.94

 

 

The following table summarizes stock option information as of March 31, 2017:

 

Exercise Prices

 

 

Outstanding

 

 

Weighted Average Contractual Life

 

Exercisable

 

$ 7,500.00

 

 

 

12

 

 

4.88 Years

 

 

12

 

$ 250.00

 

 

 

90

 

 

8.35 Years

 

 

90

 

Total

 

 

 

102

 

 

7.94 Years

 

 

102

 

 

Warrants

 

On March 27, 2015, the Company granted a non-qualified cashless stock warrant to its officer as compensation for his services. The officer is entitled to purchase a total of one thousand two hundred (1,200) shares of restricted common stock for a price equal to $750.00 per share (Exercise Price), exercisable over a five-year period thereafter. The total fair value of these warrants at the date of grant was estimated to be $813,827 and was determined using the Black-Scholes option pricing model with an expected life of 5 years, a risk-free interest rate of 1.42%, a dividend yield of 0% and expected volatility of 207.12%. As of March 31, 2017, the warrants to purchase 1,200 shares of common stock are outstanding and exercisable.

 

 
F-24
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On August 17, 2015, the Company issued 2,063 warrants in conjunctions with a convertible note issued by the Company with an estimated value of $412,698. The warrants have an exercise price of $270.00, subject to adjustment, and expire on August 17, 2020. As of March 31, 2017, the warrants to purchase 2,063 shares of common stock are outstanding and exercisable.

 

For the year ended March 31, 2017, the Company did not grant any warrants, and there were no exercises of any existing warrants. The following table summarizes the activity related to warrants of the Company for the year ended March 31, 2017, and 2016:

 

 

 

Number of Warrants

 

 

Weighted-Average Exercise Price per share

 

 

Weighted-Average Remaining Life (Years)

 

Outstanding April 1, 2015

 

 

1,266

 

 

$ 870

 

 

 

5.00

 

Granted

 

 

2,063

 

 

 

270

 

 

 

5.00

 

Cancelled/expired

 

 

(66 )

 

 

(3,049 )

 

 

-

 

Outstanding at March 31, 2016

 

 

3,263

 

 

$ 446.52

 

 

 

4.24

 

Outstanding and exercisable at March 31, 2017

 

 

3,263

 

 

$ 446.52

 

 

 

3.24

 

 

NOTE 8 - Income Taxes 

 

The Company has a deferred tax asset as shown in the following: 

 

 

 

2017

 

 

2016 

 

Deferred tax asset: 

 

 

 

 

 

 

Tax loss carryforward 

 

$ 4,068,832

 

 

$ 3,833,589

 

Stock and warrant compensation

 

 

733,673

 

 

 

704,167

 

Depreciation and amortization

 

 

954,834

 

 

 

710,023

 

Derivative expense

 

 

492,024

 

 

 

518,139

 

Other

 

 

461,558

 

 

 

461,558

 

Valuation allowance 

 

 

(6,710,921 )

 

 

(6,227,476 )

Net deferred tax asset

 

$ -

 

 

$ -

 

 

A valuation allowance has been recognized to offset the deferred tax assets because realization of such assets is uncertain. 

 

The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income statutory tax rates to pretax income (loss) from continuing operations as follows: 

 

 

 

2017

 

 

2016

 

Tax benefit at statutory rates 

 

$ 483,445

 

 

$ 3,064,131

 

Valuation allowance 

 

$ (483,445 )

 

$ (3,064,131 )

Net provision for income taxes 

 

$ -

 

 

$ -

 

 

Reconciliation of the differences between income tax benefit computed at the federal and state statutory tax rates and the provision for income tax benefit for the years ended March 31, 2017 and 2016 is as follows:

 

 

 

2017

 

 

2016 

 

Income tax expense (benefit) at federal statutory rate

 

(34.00%)

 

 

(34.00%)

 

State taxes, net of federal benefit

 

(4.63%)

 

 

(4.63%)

 

Change in valuation allowance

 

 

38.63%

 

 

38.63%

 

The Company has net operating loss carry-forwards of approximately $11,967,000 at March 31, 2017, that expire beginning in 2026. However, utilization of these losses may be limited pursuant to Section 382 of the Internal Revenue Code due to a recapitalization and subsequent stock issuances. 

 

 
F-25
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

NOTE 9 - Commitments and Contingencies

 

Legal Matters

 

The Company is not a party to any significant pending legal proceedings other than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.

 

On or about April 13, 2015, the Company was served with a lawsuit filed by an individual residing in the State of California against the Company and numerous other defendants, with a cause of action against the Company for its alleged participation in sending "spam" emails to the individual. The Company did not participate in sending any emails to the individual, retained California litigation counsel, and filed a demurrer in California. On, or about, June 3, 2015, the Company entered into a settlement agreement, and the case against the Company was subsequently dismissed with prejudice. Pursuant to the settlement agreement the Company paid $7,500.

 

On January 27, 2016, one of the Company’s creditors, JSJ Investments Inc. (“JSJ”), sent a demand for payment of amounts allegedly owed by the Company to JSJ pursuant to a convertible note dated January 19, 2015, in the original principal amount of $100,000, and threatening potential legal action against the Company. On or about September 5, 2017, JSJ assigned its interest in the note to Carebourn Partners, LLC, and the Company and JSJ mutually released each other from all claims.

 

On September 6, 2016, TCA commenced an action against the Company and the Company’s CEO, Dr. Cellucci, as “validity guarantor,” filed in the Circuit Court of the 17 th  Judicial Circuit in and for Broward County, Florida, for amounts owed to TCA by the Company under their revolving credit agreement with the Company. On April 21, 2017, the Company, Dr. Cellucci and TCA executed a settlement agreement (the “Settlement Agreement”). Pursuant to the Settlement Agreement, the Company agreed to pay $2,500 by April 30, 2017, $2,500 by May 31, 2017, and $405,357 on or before June 16, 2017. The Company fully complied with its obligations under the settlement agreement, paying TCA all amounts owed thereunder within the times required, and the case has now been dismissed.

 

On or about December 7, 2016, Bears Global Construction Holdings LLC (“Bears”) commenced an action against the Company in the County Court at Law No. 1 for Travis County, Texas, the Company denied liability and filed a counterclaim and motion to dismiss, and the parties entered into a settlement agreement on or about February 23, 2017, whereby they each released the other party from all claims. The case was subsequently dismissed.

 

NOTE 10 - Subsequent Events 

 

From April 1, 2017, through September 27, 2017, the Company has issued 5,477,480,814 shares of common stock in satisfaction of $1,107,987 and $190,701 of principal and accrued interest, respectively, pursuant to conversion notices received by the Company from convertible debt holders.

 

From April 1, 2017 through September 27, 2017, our CEO has advanced to the Company, or made payments directly to vendors of the Company, in the aggregate $22,801. On May 4, 2017, and August 11, 2017, the Company repaid our CEO $38,151 and $11,500, respectively, of amounts previously advanced.

 

On May 1, 2017, the Company issued to a third-party investor, three convertible notes, two of which were for $50,000 each and one for $17,500, and three back-end convertible notes, two of which were for $50,000 each and one for $25,000. All of the notes have a stated interest of 8% and each note is convertible at any time following the funding of such note, into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six- month anniversary of the note the conversion price shall have ceiling of $0.0005. The three convertible notes were funded on May 1, 2017, when the Company received proceeds of $111,625, after disbursements for the lender’s transaction costs, fees and expenses. On August 8, 2017, the investor funded the $25,000 back end note when the Company received $23,750 after disbursements for the lender’s transaction costs, fees and expenses.

 

On May 1, 2017, the Company issued to a third-party investor, three convertible notes, two of which were for $50,000 each and one for $17,500, and three back-end convertible notes, two of which were for $50,000 each and one for $25,000. All of the notes have a stated interest of 8% and each note is convertible at any time following the funding of such note, into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six- month anniversary of the note the conversion price shall have ceiling of $0.0005. The three convertible notes were funded on April 28, 2017, and May 3, 2017, when the Company received proceeds of $85,000 and $26,625, respectively, after disbursements for the lender’s transaction costs, fees and expenses. On August 8, 2017, the investor funded the $25,000 back end note when the Company received $23,750 after disbursements for the lender’s transaction costs, fees and expenses.

 

 
F-26
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On May 2, 2017, the Company issued a convertible note for legal services previously provided with a face value of $23,000 and stated interest of 10% to a third-party investor. The note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 70% of the average of the three lowest closing bid prices for 10 days prior to conversion.

 

On May 3, 2017, the Company issued a convertible promissory note, with a face value of $124,775 and stated interest of 10% to a third-party investor. The note is convertible at any time after ninety days following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note was funded on May 4, 2017, when the Company received proceeds of $100,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires 240 daily payments of $520 per day via ACH.

 

On May 3, 2017, the Company issued three replacement notes to a third-party investor. The replacement notes were in the amounts of $22,000, $29,700 and $25,300 and replaced notes issued in the amounts of $20,000, $27,000 and $23,000, respectively. The three replacement notes have a stated interest of 8% and each note is convertible at any time into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six-month anniversary of the notes the conversion price shall have ceiling of $0.0005. As of June 30, 2017, the principal balance of the three replacement notes in the aggregate is $77,000.

 

On June 6, 2017, the Company entered into a Strategic Alliance Agreement with HelpComm, Inc. (“HelpComm”), a telecom construction services corporation located in Manassas, Virginia, pursuant to which (i) the Company will provide at least $200,000 in business expansion funding to HelpComm within ten (10) business days of execution of the agreement, and 40% of profits from services performed by HelpComm pursuant to receipt of the expansion funding from the Company will be allotted to the Company, (ii) the Company will provide HelpComm up to an additional $100,000 of expansion funding per fiscal quarter, (ii) HelpComm will provide job-related purchase orders to the Company for administration, accounting and fund distribution, (iii) the Company will provide project management and sales services to HelpComm, and (iv) the parties will support each other’s marketing and promotional efforts. The Company remitted the $200,000 to HelpComm on June 26, 2017.

 

On June 8, 2017, the Company issued to a third-party investor a convertible promissory note for $140,750 and a back-end convertible note for $140,750. The notes have a stated interest of 8% and each note is convertible at any time following the funding of such note into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six-month anniversary of the note the conversion price shall have ceiling of $0.0005. The note was funded on June 15, 2017, when the Company received proceeds of $135,000, after disbursements for the lender’s transaction costs, fees and expenses.

 

On June 8, 2017, the Company issued to a third-party investor a convertible promissory note for $140,750 and a back-end convertible note for $140,750. The notes have a stated interest of 8% and each note is convertible at any time following the funding of such note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 55% of the lowest traded price for 20 days prior to conversion. Beginning on the six-month anniversary of the note the conversion price shall have ceiling of $0.0005. The note was funded on June 15, 2017, when the Company received proceeds of $135,000, after disbursements for the lender’s transaction costs, fees and expenses.

 

On June 9, 2017, the Company issued a convertible promissory note, with a face value of $165,025 and stated interest of 10% to a third-party investor. The note is convertible at any time after ninety days following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note was funded on May 12, 2017, when the Company received proceeds of $135,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires 240 daily payments of $680 per day via ACH.

 

On June 23, 2017, the Company issued a convertible promissory note, with a face value of $262,775 and stated interest of 10% to a third-party investor. The note is convertible at any time after ninety days following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest closing bid prices for 20 days prior to conversion. The note was funded on June 23, 2017, when the Company received proceeds of $220,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires 180 daily payments of $1,460 per day via ACH.

 

 
F-27
 
Table of Contents

 

BRAVATEK SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

MARCH 31, 2017

 

On July 10, 2017, the Company filed an Affidavit of Claim in the amount of $552,444 with The Hanover Insurance Company as surety for YKTG, related to YKTG’s alleged breaches of contract and failure to cure.

 

On July 12, 2017, the Company entered into a Settlement Agreement and Mutual Release with a holder of a note payable. The Company paid $9,000 and mutual releases between the parties, in full settlement of the note payable of $20,000.

 

On July 25, 2017, the Company entered into a Settlement Agreement with a vendor regarding previous services provided by the vendor to the Company. The parties agreed to settle the outstanding liability of $6,545 for $1,348, which the Company remitted to the vendor on July 25, 2017.

 

On August 1, 2017, Dr. Cellucci as collateral security, pledged 111,884 shares of his Series C Preferred Stock to the convertible promissory notes issued to Carebourn on the following dates and amounts; February 8, 2016 $80,000, March 24, 2016, $19,000, June 3, 2016, $42,350, May 3, 2017, $124,775, June 9, 2017, $165,025 and June 23, 2017, $262,775. This pledge replaces the pledge dated March 23, 2016.

 

On August 1, 2017, the Company issued a convertible promissory note, with a face value of $181,700, maturing on February 1, 2018 (the “Maturity Date”) and stated interest of 10% to More Capital. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices quoted for the 20 days prior to conversion. The note was funded on August 3, 2017, when the Company received proceeds of $150,000, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires daily ACH payments beginning on September 5, 2017, in the amount equal to the remaining balance on September 5, 2017, divided by the remaining days to the Maturity Date. As of September 27, 2017, the lender has converted $130,351 of the note in exchange for 141,330,143 restricted shares of common stock. As of September 27, 2017, the note balance is $51,349.

 

On August 2, 2017, the Company entered into a Strategic Alliance Agreement, dated August 3, 2017, with ProActive IT (“ProActive”), an Illinois corporation that provides information technology products and services, designating ProActive as the Company’s sales agent for government departments/agencies/units and privately owned and publicly traded companies within the State of Illinois, and providing for the cross-promotion of the parties’ products and services.

 

On August 7, 2017, the Company issued a convertible promissory note, with a face value of $223,422 and stated interest of 10% to Carebourn. The note is convertible at any time following the funding of the note into a variable number of the Company's common stock, based on a conversion ratio of 60% of the average of the three lowest trading prices for the 20 days prior to conversion. The note was funded on August 9, 2017, when the Company received proceeds of $186,280, after disbursements for the lender’s transaction costs, fees and expenses. The note also requires 240 daily payments of $931 per day via ACH.

 

On August 10, 2017, the Company entered into a Strategic Alliance Agreement, dated August 10, 2017, with CrucialTrak Inc. (“CrucialTrak”), a Texas corporation engaged in providing identification technology that delivers improved security with effective use of servers and workstations for the purpose of identifying those entering a building, office or other secured space. The Strategic Alliance Agreement designates the Company as the project- based business partnership channel for government departments, agencies and units for the purpose of promoting CrucialTrak’s relevant products and service solutions delivered through CrucialTrak’s designated distribution affiliate(s) or channel(s).

 

In August 2017, the Company entered into three Settlement Agreements with vendors that were owed in the aggregate $94,524. Pursuant to the three Settlement Agreements, in August 2017, the Company remitted $48,113 in the aggregate to the three vendors.

 

On August 25, 2017, the Company entered into a Strategic Alliance Agreement, dated August 24, 2017, with AmbiCom Holdings Inc. (“AMBICOM”), a Nevada corporation engaged in acquiring and investing in technology, designating the Company as AMBICOM’s non-exclusive sales lead finder and project-based business partnership channel for governmental and non-governmental departments, agencies and units, for the purpose of promoting AMBICOM’S technologies, and pursuant to which AMBICOM will cross-promote the Company’s products and services, the Company will investigate and propose new joint investment opportunities for AMBICOM and the Company, and the Company will be paid sales commissions for clients introduced to AMBICOM by the Company.

 

On September 5, 2017, the Company entered into a Strategic Alliance Agreement with DarkPulse Technology Holdings, Inc. (“DarkPulse”), a New York corporation engaged in manufacturing hardware and software based on its BOTDA (Brillouin Optical Time Domain Analysis) technology, designating the Company as DarkPulse’s project-based business partnership channel for governmental and non-governmental departments, agencies and units, for the purpose of promoting DarkPulse’s products, and pursuant to which DarkPulse will cross-promote the Company’s products and services, and the Company will be paid sales commissions for clients introduced to DarkPulse by the Company

 

 
F-28
 
 

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.  

 

We have had no disagreements with our accountants required to be disclosed pursuant to Item 304 of Regulation S-K.

 

ITEM 9A. CONTROLS AND PROCEDURES.

 

Disclosure Controls and Procedures 

 

The Securities and Exchange Commission defines the term "disclosure controls and procedures" to mean the company's controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the "Exchange Act") is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC's rules and forms and that information required to be disclosed is accumulated and communicated to principal executive and principal financial officers to allow timely decisions regarding disclosure.

 

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are not designed to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report to provide reasonable assurance of the achievement of these objectives.

 

Internal Control Over Financial Reporting 

 

The management of the Company is responsible for the preparation of the financial statements and related financial information appearing in this Annual Report on Form 10-K. The financial statements and notes have been prepared in conformity with accounting principles generally accepted in the United States of America. The management of the Company also is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. A company's internal control over financial reporting is defined as a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements. 

 

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company's internal controls will prevent all error and all fraud. Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable, not absolute, assurance that the objectives of the control system are met and may not prevent or detect misstatements. Further, over time control may become inadequate because of changes in conditions or the degree of compliance with the policies or procedures may deteriorate. 

 

 
16
 
 

 

With the participation of the Chief Executive Officer and Chief Financial Officer, our management evaluated the effectiveness of the Company's internal control over financial reporting as of March 31, 2017, based upon the framework in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, our management has concluded that the Company's internal controls over financial reporting were not effective as of March 31, 2017. A material weakness due to a failure by the Company to properly record and value conversions of convertible debt and related stock transactions relating to convertible notes issued by the Company was observed. To remediate the weaknesses in our internal controls over financial reporting, we intend to: i) reconcile stock issuance transactions against the agreements underlying such stock issuance transactions to ensure that equity issuances are properly accounted for; and ii) implement a review board to review the stock issuance transactions to ensure that they are properly valued and accounted for. 

 

This annual report does not include an attestation report of the Company's registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit us to provide only management's report in this Annual Report on Form 10-K.

 

Except as disclosed herein, there was no significant change in the Company's internal control over financial reporting during the last fiscal quarter, that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION. 

 

None

 

 
17
 
 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE.  

 

Directors, Executive Officers and Significant Employees

 

The following table sets forth, as of March 31, 2017, the respective positions and ages of our directors and executive officers of the Company. Each director has been elected to hold office until the next annual meeting of shareholders and thereafter until his successor is elected. Vacancies in the existing Board of Directors are filled by majority vote of the remaining Directors. There are no agreements or understandings for any officer or director to resign at the request of another person and no officer or director is acting on behalf of or will act at the direction of any other person.

 

Name 

Age 

Position 

Director or Officer Since 

Dr. Thomas A. Cellucci

59

Chief Executive Officer

Director 

June 17, 2014 

March 27, 2014

 

 

 

 

 

 

 

Deborah King

57

Director 

CFO

March 16, 2015 

August 6, 2015

 

Charles Brooks

60

Director 

March 16, 2015

 

 

 

 

 

 

 

Hans Holmer

 

56

 

Director

 

September 1, 2015

 

Biographical Information 

 

Dr. Thomas A. Cellucci  - Dr. Thomas A. Cellucci ("Dr. Cellucci") currently serves as the Chief Executive Officer and a Director of the Company. Additionally, from 1999 to the present, Dr. Cellucci serves as the Chairman and CEO of Cellucci Associates, a high-tech marketing firm focused on developing business and marketing plans for worldwide high-tech firms.

 

From 2013 to the present, Dr. Cellucci serves as the Executive Director at AGVE (Alliance for Government Virtual Engagements) located in Washington DC. AGVE is a non-profit dedicated to fostering technology-focused bridges, best practices and communications between government and the private sector to enable high performance/price business operations for government. He is also the Founding and Managing Partner of Union Core Technology Partners, a private equity fund.

From 2007 to 2011, Dr. Cellucci served as the First Chief Commercialization Officer of the United States of America, where he was responsible for overseeing the development and execution of programs and processes that identified, evaluated, and commercialized privately owned technologies into products or services that meet the needs of the Department of Homeland Security's (DHS) stakeholders, including DHS operating components and end users such as the nation's first responders, and critical infrastructure owner/operators.

 

During his tenure as the Chief Commercialization Officer, in 2010 Dr. Cellucci was also appointed as the Director of the Office of Public-Private Partnerships, which oversees the Long Range Broad Agency Announcement (LRBAA) procurement process, Office of SAFETY Act Implementation (OSAI), Small Business Innovation Research (SBIR) Office as well as the Commercialization Office. At this same time, Dr. Cellucci was also named Executive Director of the Research and Development (R&D) Partnerships Group responsible to leverage the billions of dollars in assets and the expertise of more than 1300 team members through the group's investments in national labs, universities, international partners, the private sector and government interagency partners to develop technologies and products for the Homeland Security Enterprise (HSE).

 

Dr. Cellucci earned a PhD in Physical Chemistry from the University of Pennsylvania, an MBA from Rutgers University and a BS in Chemistry from Fordham University. He has also attended and lectured at executive programs at the Harvard Business School, MIT Sloan School, Kellogg School and others.

 

Between 1978 and 1991 Dr. Cellucci was Chemistry Lecturer at Fordham University, the University of Pennsylvania, and Princeton University, as well as Professor of Physics and Laser/Electro-Optic Technology at Camden County College.

 

 
18
 
 

 

Deborah King (a/k/a Debbie King)  - Ms. King possesses over 25 years of entrepreneurial leadership experience and has served as a business and financial advisor to a number of firms in her career. She currently serves as the Business Manager to a privately held firm in Dallas, Texas, and brought a unique set of skills to her position including financial, operations, and business management. Ms. King has assisted a number of firms in business start-up, acquisition, expansion, and reorganization. She possesses a diverse skill set that allows a broad perspective of business financial and operations management. Ms. King's background as an accountant has allowed her to serve numerous firms in various industries in optimizing profit outputs and streamlining business practices. She is a strong-minded and focused individual that utilizes her education and experience to assist in analyzing, identifying and implementing operational changes to increase efficiency and profits. Ms. King possesses a broad knowledge in financial, legal and business tax applications. 

 

Charles Brooks  - Charles Brooks currently serves as the Vice President of Government Relations & Marketing for Sutherland Global Services. Mr. Brooks has extensive experience in Senior Executive Management, Government Relations, Research & Development, and Marketing/Business Development and worked in those capacities for three large public corporations. He also received Presidential Appointments from two Presidents, George W. Bush and Ronald Reagan, to serve in executive roles in the federal government. Mr. Brooks served at the Department of Homeland Security as the first Director of Legislative Affairs for the Science & Technology Directorate. Earlier in his career he served as Special Assistant to the Director of Voice of America. He also spent six years on Capitol Hill as a Senior Advisor to the late Senator Arlen Specter where he covered foreign affairs, business, and technology issues. In academia, Mr. Brooks was an Adjunct Faculty Member at Johns Hopkins University where he taught graduate level students about homeland security and Congress. 

 

Mr. Brooks has an MA in International Relations from the University of Chicago, a BA in Political Science from DePaul University, and a Certificate in International Law from The Hague Academy of International Law. He is a featured speaker at conferences and is widely published on the subjects of cybersecurity, homeland security, innovation, public/private partnerships, and emerging technologies. Those publications include: Huffington Post, Forbes, Government Security News, The Hill, Federal Times, Government Executive, MIT Sloan Blog, Homeland Security Today, BiometricUpdate, NextGov, and Cygnus Media. 

 

Hans Holmer - Mr. Holmer is a retired CIA officer with extensive experience in strategic cyber issues. His experience in nation-state intelligence collection and corporate defense goes back nearly 20 years and his engagement with the interface of humans and technology goes back to 1973. He spent over half of his career overseas and served on every continent except South America. Among other awards, Mr. Holmer has received the CIA Intelligence Star "in recognition of his especially valorous performance of duty."

 

Within the cyber realm, Mr. Holmer became an expert in conventional computer networks, telephony, Industrial Control Systems, and defensive strategies. He developed the Cyber Security Hierarchy, analogous to the Maslow hierarchy of human needs, which outlines a hierarchy of needs that must be satisfied to achieve cyber security. It postulates that effective cyber security requires adequate resources, integration with the corporate business processes, esteem for cyber security requirements and the agility to respond to threats in order to have adequate impact.

 

From May of 2013 through the present, Mr. Holmer has worked for Intelligent Decisions, Inc., and before that, he worked for the Central Intelligence Agency. Mr. Holmer is not a director of any other public companies.

 

Family Relationships

 

None.

 

 
19
 
 

 

Involvement in Certain Legal Proceedings 

 

To the best of its knowledge, the Company's directors and executive officers were not involved in any legal proceedings during the last ten years as described in Item 401(f) of Regulation S-K. 

 

Directorships 

 

None of the Company's executive officers or directors is a director of any company with a class of equity securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of the Exchange Act or any company registered as an investment company under the Investment Company Act of 1940. 

 

Compliance with Section 16(a) of the Exchange Act 

 

Section 16(a) of the Exchange Act requires the Company’s directors and named executive officers, and persons who beneficially own more than 10% of a registered class of our equity securities to file initial reports of ownership and reports of changes in ownership of our common stock and our other equity securities with the SEC. Upon information and belief, our CEO did not file a Form 4 upon receipt of preferred shares in exchange for common stock on or about July 20, 2015, our other directors did not file Form 3’s upon their appointment as directors of the Company on March 16, 2015 (for Ms. King and Mr. Brooks), and September 1, 2015 (for Mr. Holmer), and our directors did not file Form 4’s for the receipt of options described in Item 11 below.

 

Code of Ethics 

 

The Company has adopted a code of ethics, as required by the rules of the SEC, a copy of the Company's code of ethics was filed as Exhibit 14.1 to Form 10-K for the fiscal year ended March 31, 2010, filed with the Securities and Exchange Commission on July 13, 2010, and is hereby incorporated by reference. The code of ethics applies to all of the Company's senior financial officers. The code of ethics, and any amendments to, or waivers from, the code of ethics, is available in print, at no charge, to any stockholder who requests such information. 

 

ITEM 11. EXECUTIVE COMPENSATION

 

Executive Compensation 

 

The following table sets forth, for the years indicated, all compensation paid, distributed or accrued for services, including salary and bonus amounts, rendered in all capacities by the Company's chief executive officer, chief financial officer and all other executive officers who received or are entitled to receive remuneration in excess of $100,000 during the stated periods.

Name and principal position

 

For Fiscal Year Ending

March 31,

 

Salary

$

 

 

Stock Options

$

 

 

Option Awards

$

 

 

Total

$

 

Brad Lever, COO, CFO & Director (1)

 

2017

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

2016

 

 

4,500

 

 

 

-0-

 

 

 

-0-

 

 

 

4,500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dr. Thomas A Cellucci, CEO & Director (2)

 

2017

 

 

140,000

 

 

 

-0-

 

 

 

-0-

 

 

 

140,000

 

 

 

2016

 

 

274,000

 

 

 

-0-

 

 

 

-0-

 

 

 

274,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deborah King, CFO, & Director (3)

 

2017

 

 

72,000

 

 

 

-0-

 

 

 

-0-

 

 

 

72,000

 

 

 

2016

 

 

35,000

 

 

 

-0-

 

 

 

7,875

 

 

 

42,975

 

____________

(1)

On March 11, 2015, Brad Lever resigned as Director. On May 12, 2015, Brad Lever resigned as COO and CFO, respectively.

(2)

Dr. Cellucci was named CEO of the Company on June 17, 2014. Pursuant to Dr. Cellucci’s employment agreement, as amended, the Company currently accrues compensation of $12,500 per month for his services as CEO of the Company. The Company also accrues $1,500 a month to Dr. Cellucci as reimbursement for health and dental insurance costs. On March 27, 2015, Dr. Cellucci was granted a warrant to purchase 1,200 shares of the Company's common stock at a $750.00 per share exercise price, exercisable on a cashless basis, having a term of 5 years, and vested immediately on March 27, 2015. As of March 31, 2017, the Company owed Dr. Cellucci $243,000 (included in accounts payable, related party on the March 31, 2017, balance sheet presented herein) for the expensed but unpaid part of the above reported salary.

(3)

Ms. King was named CFO of the Company on August 6, 2015. Pursuant to Ms. King’s consulting agreement, as amended, the Company currently compensates Ms. King for her services as CFO of the Company at $5,000 per month. As of March 31, 2017, the Company owed Ms. King $37,750 (included in accounts payable, related party on the March 31, 2017, balance sheet presented herein) for the expensed but unpaid part of the above reported salary.

 

 
20
 
 

 

Option Grants in Last Fiscal Year 

 

The Company did not issue any options during the year ended March 31, 2017.

 

Equity Compensation Plan Information

 

On April 12, 2011, subject to shareholder approval, the Board of Directors of Bravatek, Inc. (the "Company") approved the adoption of the Bravatek, Inc. Stock Compensation Program (the "Program") under which 540 shares have been reserved for purposes of possible future issuance of incentive stock options, non-qualified stock options, and restricted stock grants to employees, directors and certain key individuals. On April 15, 2011, pursuant to a written consent in lieu of a meeting, a majority of the Company's shareholders approved the Program. The purpose of the Program is to attract and retain key employees, consultants and other persons, and to provide such key individuals with an additional incentive to contribute to the success of the Company. In order to maintain flexibility in the award of stock benefits, the Program constitutes a single "omnibus" plan, but is composed of three parts. The first part is the Incentive Stock Option Plan ("Incentive Option Plan) which provides grants of incentive stock options under Section 422A of the Internal Revenue Code of 1986, as amended. The second part is the Nonqualified Stock Option Plan ("Nonqualified Option Plan") which provides grants of nonqualified stock options. The third part is the Restricted Shares Plan ("Restricted Plan") which provides grants of restricted shares of Company common stock. The Incentive Option Plan, the Nonqualified Option Plan and the Restricted Plan respectively comprise Plan I, Plan II, and Plan III of the Program. The foregoing description of the Program is qualified in its entirety by reference to the Bravatek, Inc. Stock Compensation Program which was filed as Exhibit 10.9 to Form 8-K filed with the Securities and Exchange Commission on April 20, 2011 and is hereby incorporated by reference. 

 

Compensation Agreements 

 

Dr. Thomas Cellucci’s Employment Agreement with the Company, as amended, includes compensation of $12,500 per month for his services as Chief Executive Officer and $1,500 in health insurance reimbursements. On March 27, 2015, Dr. Cellucci was granted a warrant to purchase 1,200 shares of the Company's common stock at a $750 per share exercise price, exercisable on a cashless basis, having a term of 5 years, and vesting immediately on March 27, 2015. As of March 31, 2017, the Company owed Dr. Cellucci $243,000 (included in accounts payable, related party on the March 31, 2017, balance sheet presented herein) for the expensed but unpaid part of the above reported salary

 

Director Compensation 

 

Our Board of Directors is comprised of Dr. Cellucci, Messrs. Brooks and Holmer and Ms. King. The compensation of Dr. Cellucci and Ms. King is disclosed in the Executive Compensation table, and Dr. Cellucci and Ms. King were not compensated separately for their services as directors. The following table provides summary information concerning compensation awarded to, earned by, or paid to any of our directors for all services rendered to the Company in all capacities for the fiscal year ended March 31, 2017.

 

Name and Principal Position

 

Fees Earned and Paid in Cash

($)

 

 

Stock

Awarded

($)

 

 

Options

Awarded

($)

 

 

Total

($)

 

Charles Brooks (1)

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hans Holmer (2)

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

______________

(1)

Charles Brooks was appointed Director on March 16, 2015

(2)

Hans Holmer was appointed Director on September 1, 2015.

 

 
21
 
 

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.  

 

Equity Compensation Plan 

 

As disclosed on Form 8-K filed with the Securities and Exchange Commission on April 20, 2011, on April 12, 2011, subject to shareholder approval, the Board of Directors of Bravatek, Inc. (the "Company") approved the adoption of the Bravatek, Inc. Stock Compensation Program (the "Program") under which 540 shares have been reserved for purposes of possible future issuance of incentive stock options, non-qualified stock options, and restricted stock grants to employees, directors and certain key individuals. On April 15, 2011, pursuant to a written consent in lieu of a meeting, a majority of the Company's shareholders approved the Program. The purpose of the Program is to attract and retain key employees, consultants and other persons, and to provide such key individuals with an additional incentive to contribute to the success of the Company. In order to maintain flexibility in the award of stock benefits, the Program constitutes a single "omnibus" plan, but is composed of three parts. The first part is the Incentive Stock Option Plan ("Incentive Option Plan) which provides grants of incentive stock options under Section 422A of the Internal Revenue Code of 1986, as amended. The second part is the Nonqualified Stock Option Plan ("Nonqualified Option Plan") which provides grants of nonqualified stock options. The third part is the Restricted Shares Plan ("Restricted Plan") which provides grants of restricted shares of Company common stock. The Incentive Option Plan, the Nonqualified Option Plan and the Restricted Plan respectively comprise Plan I, Plan II, and Plan III of the Program. The foregoing description of the Program is qualified in its entirety by reference to the Bravatek, Inc. Stock Compensation Program which was filed as Exhibit 10.9 to Form 8-K filed with the Securities and Exchange Commission on April 20, 2011. The chart below identifies information with respect to the Stock Compensation Plan: 

 

The following table sets forth, as of September 27, 2017, the number of securities approved and available for future issuances under the Company's Stock Compensation Program. 

 

Plan category 

 

Number of securities to be issued upon exercise of outstanding options, warrants

 

 

Weighted average exercise price of outstanding options, warrants

 

 

Number of securities remaining available for future issuances under equity compensation plans (excluding securities reflected in column (a))

 

 

 

(a) 

 

 

(b) 

 

 

(c) 

 

 

 

 

 

 

 

 

 

 

 

Equity compensation plans approved by security holders 

 

 

102

 

 

$ 1,102.94

 

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity compensation plans not approved by security holders 

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total 

 

 

102

 

 

$ 1,102.94

 

 

 

-0-

 

 

 
22
 
 

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following tables set forth certain information regarding the beneficial ownership of our voting securities (Common Stock and Series C Preferred Stock) as of September 27, 2017, of (i) each person known to us to beneficially own more than 5% of our stock, (ii) our directors, (iii) each named executive officer, and (iv) all directors and named executive officers as a group. As of September 27, 2017, there were a total of 7,531,184,221 shares of Common Stock issued and outstanding, and 319,768 shares of Series C Preferred Stock issued and outstanding.

 

The number of shares beneficially owned is determined under the rules promulgated by the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under those rules, beneficial ownership includes any shares as to which a person or entity has sole or shared voting power or investment power plus any shares which such person or entity has the right to acquire within sixty (60) days of September 27, 2017, through the exercise or conversion of any stock option, convertible security, warrant or other right. Unless otherwise indicated, each person or entity named in the table has sole voting power and investment power (or shares such power with that person's spouse) with respect to all shares of capital stock listed as owned by that person or entity, and the address of each of the stockholders listed below is: c/o Bravatek Solutions, Inc. 2028 E. Ben White Blvd, Suite 240-2835, Austin, Texas 78741. 

 

Title of Class

 

Name and Address

 

Number of Shares Beneficially Owned

 

Percent of

Class (1)

 

Common Stock

 

Dr. Thomas A. Cellucci, CEO & Director

 

895

(2)

 

*

%

 

Common Stock

 

Debbie King, CFO & Director

 

30

(3)

 

*

%

 

Common Stock

 

Chuck Brooks, Director

 

30

(3)

 

*

%

 

Common Stock

 

Hans Holmer, Director

 

30

(3)

 

*

%

 

Common Stock

 

All Directors and Officers as a Group

 

985

 

*

%

 

Series C Preferred Stock

 

Dr. Thomas A. Cellucci, CEO & Director

 

223,768

 

70

%

 

Series C Preferred Stock

 

All Directors and Officers as a Group

 

223,768

 

70

%

________________

*

Less than 0.01%

(1)

Applicable percentages of ownership are based on 7,531,184,221 shares of our Common Stock and 319,768 shares of Series C Preferred Stock issued and outstanding as of September 27, 2017. Beneficial ownership is determined in accordance with rules of the Securities and Exchange Commission and means voting or investment power with respect to securities. Shares of our Common Stock issuable upon the exercise of stock options exercisable, or convertible securities convertible, currently or within 60 days of September 27, 2017, are deemed outstanding and to be beneficially owned by the person holding such option for purposes of computing such person's percentage ownership, but are not deemed outstanding for the purpose of computing the percentage ownership of any other person.

(2)

Dr. Cellucci owns -0- shares of Common Stock, however, his Series C Preferred Stock is convertible into 895 shares of Common Stock. Each share of Series C Preferred stock entitles the holder thereof to 10,000 votes on all matters submitted to a vote of the stockholders of the Company. Dr. Cellucci has pledged his Series C Preferred Stock as collateral for certain of the issued convertible notes of the Company.

(3)

Includes 30 shares of Common Stock issuable pursuant to vested stock options.

 

 
23
 
 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.  

 

Related Transactions 

 

On June 2, 2015, the Company completed an acquisition of some of the assets and assumed certain liabilities of Viking Telecom Services, LLC (“Viking Telecom”) from Dependable Critical Infrastructure, Inc. (“DCI”), f/k/a DTREDS Consolidated, Inc. To acquire the assets, the Company issued 2,265 shares of common stock, 224 shares of common stock to be issued (valued in the aggregate at $740,000), paid $200,000 cash and forgave $59,204 of a note receivable from DCI. The Company now provides telecom services under a new Viking Telecom brand. Services provided by Viking Telecom include cellular tower mapping and audits, ground audits, civil equipment installation, cellular site decommissioning, 3G/4G installations, project/construction management, battery installation and maintenance, shelter and compound preventative maintenance, site cleanup, and other related services. The Company’s Chief Executive Officer owned approximately 30% of DCI. The Company recorded a loss on the acquisition of $1,044,817 for the year ended March 31, 2016.

 

The Company issued multiple unsecured notes payable from June 27, 2015 to March 31, 2017, to the Company’s CEO, for amounts received by the Company, or paid by the CEO, on behalf of the Company, totaling $188,362 (of which $31,850 was during the year ended March 31, 2017). The advances carry interest at 10% per annum and are due on demand. The Company recorded related party interest expense of $11,603 for the year ended March 31, 2017. During the year ended March 31, 2017, the Company made repayments of $12,224 of principal. As of March 31, 2017, the principal balance was $136,850 and the accrued and unpaid interest was $23,153.

 

There were no other material transactions, or series of similar transactions, during our Company's last fiscal year, or any currently proposed transactions, or series of similar transactions, to which our Company was or is to be a party, in which the amount involved exceeded the lesser of $120,000 or one percent of the average of the small business issuer's total assets at year-end for the last three completed fiscal years and in which any director, executive officer or any security holder who is known to us to own of record or beneficially more than five percent of any class of our common stock, or any member of the immediate family of any of the foregoing persons, had an interest. 

 

Director Independence 

 

The NASDAQ Stock Market has instituted director independence guidelines that have been adopted by the Securities & Exchange Commission. These guidelines provide that a director is deemed "independent" only if the board of directors affirmatively determines that the director has no relationship with the company which, in the board's opinion, would interfere with the director's exercise of independent judgment in carrying out his or her responsibilities. Significant stock ownership will not, by itself, preclude a board finding of independence. 

 

For NASDAQ Stock Market listed companies, the director independence rules list six types of disqualifying relationships that preclude an independence filing. The Company's board of directors may not find independent a director who: 

 

1.

is an employee of the company or any parent or subsidiary of the company;

 

2.

accepts, or who has a family member who accepts, more than $60,000 per year in payments from the company or any parent or subsidiary of the company other than (a) payments from board or committee services; (b) payments arising solely from investments in the company's securities; (c) compensation paid to a family member who is a non-executive employee of the company (d) benefits under a tax qualified retirement plan or non-discretionary compensation; or (e) loans to directors and executive officers permitted under Section 13(k) of the Exchange Act;

 

3.

is a family member of an individual who is employed as an executive officer by the company or any parent or subsidiary of the company;

 

4.

is, or has a family member who is, a partner in, or a controlling shareholder or an executive officer of, any organization to which the company made, or from which the company received, payments for property or services that exceed 5% of the recipient's consolidated gross revenues for that year, or $200,000, whichever is more, other than (a) payments arising solely from investments in the company's securities or (b) payments under non-discretionary charitable contribution matching programs; and

 

5.

is employed, or who has a family member who is employed, as an executive officer of another company whose compensation committee includes any executive officer of the listed company; or is, or has a family member who is, a current partner of the company's outside auditor, or was a partner or employee of the company's outside auditor who worked on the company's audit.

 

Based upon the foregoing criteria, our Board of Directors has determined that Dr. Cellucci (Chief Executive Officer and President) and Ms. King (Chief Financial Officer) are not independent directors under these rules.

 

 
24
 
 

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES. 

 

Audit Fees 

 

The fees billed by D. Brooks and Associates CPAs, P.A. for audit of the Company’s annual financial statements were $30,000 for each of the fiscal years ended March 31, 2017, and 2016.

 

Audit Related Fees

 

None.

 

Tax Fees 

 

None. 

 

All Other Fees 

 

None.

 

Audit Committee's Pre-Approval Policies and Procedures 

 

The Company does not have an audit committee per se. The current board of directors functions as the audit committee.

 

 
25
 
 

 

PART IV 

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

 

(b) Exhibits. 

 

Number

Description

3.1

Articles of Incorporation (incorporated by reference to our General Form for Registration of Securities on Form 10 filed on November 10, 2008)

3.2

Bylaws (incorporated by reference to our General Form for Registration of Securities on Form 10 filed on November 10, 2008)

3.3

Articles of Amendment to Articles of Incorporation (incorporated by reference to our Current Report on Form 8-K filed on April 1, 2014)

3.4

Certificate of Designation of Series B Preferred Stock (incorporated by reference to our Current Report on Form 8-K filed on July 23, 2015)

3.5

Certificate of Designation of Series C Preferred Stock (incorporated by reference to our Current Report on Form 8-K filed on July 23, 2015)

3.6

Articles of Amendment to Articles of Incorporation (changing the Company's name) (incorporated by reference to our Current Report on Form 8-K filed on November 3, 2015)

3.7

Articles of Amendment to Articles of Incorporation (increasing the Company's authorized common stock) (incorporated by reference to our Current Report on Form 8-K filed on June 6, 2016)

3.8

Articles of Amendment to Articles of Incorporation (amending the Designation of the Series C Preferred Stock) (incorporated by reference to our Current Report on Form 8-K filed on November 3, 2015)

10.1

 

Commodity Classification Document (incorporated by reference to our General Form for Registration of Securities on Form 10 filed on November 10, 2008)

 

 

    

10.2

Director Agreement and Restricted Shares Agreement dated March 27, 2014, with Thomas Cellucci (incorporated by reference to our Current Report on Form 8-K filed on April 1, 2014)

          

10.3

Employment Agreement and Restricted Shares Agreement dated June 16, 2014, with Thomas Cellucci (incorporated by reference to our Current Report on Form 8-K filed on June 18, 2014)

            

10.4

Amendments to Employment Agreement and Restricted Shares Agreement with Thomas Cellucci (incorporated by reference to our Quarterly Report on Form 10-Q filed on February 22, 2016)

            

10.5

Asset Purchase Agreement with Dependable Critical Infrastructure, Inc. dated June 2, 2015 (incorporated by reference to our Form 8-K filed on June 9, 2015)

           

10.6

Settlement Agreement with Global Capital Corporation dated June 10, 2015 (incorporated by reference to our Form 8-K filed on June 16, 2015)

      

10.7

Settlement Agreement with Micro-Tech Industries, Ltd., dated July 20, 2015 (incorporated by reference to our Form 8-K filed on July 23, 2015)

       

10.8

Settlement Agreement with Whonon Trading S.A., dated July 20, 2015 (incorporated by reference to our Form 8-K filed on July 23, 2015)

           

10.9

 

Consulting Agreement dated December 1, 2015, with Debbie King

       

10.10

 

Amendment to Consulting Agreement dated March 1, 2016, with Debbie King

  

 
26
 
 

 

10.11

Director Agreement and Nonqualified Stock Option Agreement dated July 23, 2015, with Debbie King

 

10.12

Director Agreement and Nonqualified Stock Option Agreement dated July 23, 2015, with Charles Brooks

 

10.13

 

Director Agreement and Nonqualified Stock Option Agreement dated August 26, 2015, with Hans Holmer

 

10.14

 

Reseller Agreement with i3 Integrative Creative Solutions, LLC, dated April 17, 2017 (incorporated by reference to our Form 8-K filed on April 18, 2017)

 

10.15

 

Strategic Alliance Agreement with Mile High Construction dated June 2, 2017 (incorporated by reference to our Form 8-K filed on June 2, 2017)

 

10.16

 

Strategic Alliance Agreement with HelpComm dated June 6, 2017 (incorporated by reference to our Form 8-K filed on June 7, 2017)

 

10.17

 

Letter of Intent with HelpComm dated September 20, 2017 (incorporated by reference to our Form 8-K filed on September 21, 2017)

 

 

 

14.1

Code of Ethics (incorporated by reference to our Annual Report on Form 10-K filed July 13, 2010)

31.1*

Certification of Principal Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*

Certification of Principal Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1*

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63

32.2*

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63

 

 

 

101.INS**

XBRL Instance Document

101.SCH**

XBRL Taxonomy Extension Schema Document

101.CAL**

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF**

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB**

XBRL Taxonomy Extension Label Linkbase Document

101.PRE**

XBRL Taxonomy Extension Presentation Linkbase Document

____________ 

* Filed Herewith

 

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 
27
 
 

 

SIGNATURE

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

 

 

BRAVATEK SOLUTIONS, INC.

 

Date: September 27, 2017 

By:

/s/ Thomas Cellucci  

 

Thomas Cellucci

 

Chairman and Chief Executive Officer 

 

Date: September 27, 2017 

By:

/s/ Debbie King  

Debbie King

Chief Financial Officer and Director 

 

Date: September 27, 2017 

By:

/s/ Charles Brooks  

Charles Brooks

Director 

 

 

 

 

 

 

 

 

Date: September 27, 2017 

By:

/s/ Hans Holmer

Hans Holmer

Director 

 

 

28

Bravatek Solutions (CE) (USOTC:BVTK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Bravatek Solutions (CE) Charts.
Bravatek Solutions (CE) (USOTC:BVTK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Bravatek Solutions (CE) Charts.